This article addresses the critical challenge of developing and applying pragmatic measures in implementation science to accelerate the translation of evidence-based interventions into routine practice.
This article addresses the critical challenge of developing and applying pragmatic measures in implementation science to accelerate the translation of evidence-based interventions into routine practice. Tailored for researchers, scientists, and drug development professionals, we explore the foundational need for stakeholder-engaged definitions of pragmatism, methodological frameworks for measure development, strategies for troubleshooting and optimizing implementation packages, and the vital role of validation through comparative effectiveness research. By synthesizing the latest methodologies and trends, this resource provides a comprehensive guide for creating measures and strategies that are not only scientifically rigorous but also feasible, relevant, and impactful in diverse, real-world settings.
Current approaches to developing pragmatic measures in implementation science predominantly rely on expert panels and psychometric validation. This application note identifies a critical gap in these methods: the lack of incorporation of diverse stakeholder perspectives, particularly those with lived healthcare experience. We present evidence that this limitation risks creating measures misaligned with real-world practicalities and propose structured methodologies to address this gap through participatory research designs, detailed protocols for stakeholder engagement, and innovative evaluation frameworks. By integrating these approaches, implementation science can develop truly pragmatic measures that balance methodological rigor with practical relevance across diverse healthcare contexts.
The development of pragmatic measures in implementation science has traditionally been dominated by expert-driven approaches, creating a significant disconnect between measurement tools and the practical realities of healthcare settings [1]. Pragmatic measures are designed to be relevant, feasible, and usable in real-world practice conditions, enabling stakeholders to assess implementation barriers, monitor progress, and evaluate outcomes effectively [2]. Despite the field's emphasis on practicality, current methodologies have primarily inherited definitions of pragmatism from the evidence-based healthcare movement without sufficiently incorporating perspectives from those who ultimately use these measures in practice [1].
This overreliance on expert panels has resulted in several critical limitations. Traditional approaches often prioritize psychometric properties while overlooking the practical concerns of end-users, including healthcare providers, patients, and public stakeholders with lived experience of healthcare systems [1]. The Psychometric and Pragmatic Evidence Rating Scale (PAPERS) exemplifies this trend, having been developed with limited stakeholder involvement despite its intended application in real-world settings [1]. This methodological gap risks creating measures that, while statistically sound, lack relevance and feasibility in routine practice, ultimately limiting their utility for guiding implementation efforts and informing healthcare decisions.
Table 1: Limitations of Expert-Driven Approaches to Pragmatic Measure Development
| Limitation | Impact on Measure Quality | Consequence for Implementation |
|---|---|---|
| Restricted definition of pragmatism | Narrow focus on psychometric properties over practical utility | Measures may not address real-world implementation challenges |
| Exclusion of stakeholder perspectives | Overlooking practical concerns of end-users | Reduced adoption and feasibility in routine practice settings |
| Potential for measurement bias | Fixed scales may not adapt to evolving contexts | Limited applicability across diverse populations and settings |
| Emphasis on quantitative methods | Neglect of qualitative insights and contextual factors | Incomplete understanding of implementation phenomena |
A reconceptualization of pragmatism in implementation science requires returning to its philosophical foundations. Pierce's original maxim of pragmatism states: "Consider the practical effects of the objects of your conception. Then, your conception of those effects is the whole meaning of the conception" [1]. This principle suggests that the evaluation of pragmatism must account for the constantly changing social dynamic between real-world scenarios and measurement tools, rather than relying on static, predetermined criteria.
Contemporary implementation science has primarily focused on two areas of pragmatism: (1) developing embedding methods or frameworks for practice (such as pragmatic trials or RE-AIM), and (2) creating measures to evaluate the pragmatic qualities of implementation tools [1]. The pragmatic-explanatory continuum illustrates how research designs vary in their alignment with real-world conditions, with pragmatic trials designed to evaluate effectiveness in routine practice settings rather than efficacy under optimal conditions [3]. This continuum can be visualized using tools like the PRECIS-2 framework, which assesses trials across nine domains including eligibility criteria, flexibility of interventions, and primary outcomes [4].
The fundamental challenge in evaluating pragmatism lies in the abstraction required to measure the measures themselves. Any use of a scale represents an attempt to apply theoretical constructs to complex realities, creating inherent limitations in measurement accuracy [1]. Methodological biases may further privilege certain forms of expertise and measurement approaches while neglecting diverse perspectives and exceptional cases that do not fit predetermined categories [1]. Addressing these limitations requires expanding conceptions of pragmatism and incorporating diverse voices throughout the measurement development process.
Diagram 1: Conceptual Framework for Expanded Pragmatism in Implementation Science. This diagram contrasts traditional expert-driven approaches with expanded stakeholder-informed methodologies for developing pragmatic measures.
Recent empirical investigations have documented significant limitations in how pragmatic measures are developed and evaluated. A 2025 study explicitly explored stakeholder views on pragmatic measures through participatory research methods, convening a working group of eight stakeholders with lived healthcare experience [1]. This research revealed substantial concerns about the restricted definition of pragmatism in current implementation science, potential biases in measurement approaches, and the necessity for more holistic, pluralistic methodologies that incorporate diverse perspectives when developing and evaluating implementation theory and metrics [1].
Stakeholders participating in this research identified six critical themes that highlight gaps in traditional approaches to pragmatic measurement:
These findings align with earlier research protocols that acknowledged significant gaps in measurement as among the most critical barriers to advancing implementation science [2]. A 2015 study protocol identified three fundamental issues: (a) lack of stakeholder involvement in defining pragmatic measure qualities; (b) scarcity of measures, particularly for implementation outcomes; and (c) unknown psychometric and pragmatic strength of existing measures [2].
Table 2: Documented Gaps in Pragmatic Measure Development
| Evidence Source | Primary Gap Identified | Methodological Limitation | Year |
|---|---|---|---|
| Stakeholder working group study [1] | Restricted definition of pragmatism excluding stakeholder perspectives | Overreliance on expert panels rather than participatory approaches | 2025 |
| Implementation science measurement review [5] | Majority of implementation measures lack rigorous psychometric evaluation | Context-specific measures rarely reused, limiting evidence accumulation | 2016 |
| Measure development protocol [2] | Lack of stakeholder involvement in defining pragmatic qualities | Measures developed without input from end-users in practice settings | 2015 |
| Pragmatic trials review [3] | Limited generalizability of explanatory trial results to real-world settings | Traditional designs prioritize internal validity over external validity | 2011 |
To address the critical gaps in traditional approaches, we propose a structured participatory research protocol for engaging stakeholders in pragmatic measure development:
Phase 1: Framing the Problem
Phase 2: Working Group Assembly and Debates
Phase 3: Analysis and Interpretation
For comprehensive pragmatic measure development, we recommend an expanded version of established protocols [2] incorporating stakeholder perspectives throughout:
Stage 1: Domain Delineation
Stage 2: Clarifying Internal Structure
Stage 3: Establishing Priority Criteria
Stage 4: Validation and Testing
Diagram 2: Integrated Workflow for Stakeholder-Informed Pragmatic Measure Development. This diagram illustrates the sequential phases and stages of the proposed methodology, highlighting continuous stakeholder engagement throughout the process.
Table 3: Essential Methodological Tools for Stakeholder-Informed Pragmatic Measure Development
| Research Tool | Primary Function | Application Context | Key Features |
|---|---|---|---|
| PRECIS-2 Framework [4] | Trial design assessment across pragmatic-explanatory continuum | Evaluating clinical trial designs for real-world applicability | 9-domain evaluation tool with visual "wheel" representation |
| PAPERS Rating Scale [1] | Assess pragmatic qualities of implementation measures | Evaluating usability and practicality of existing measures | Rates measures across multiple pragmatic criteria |
| Q-Sort Methodology [2] | Clarify internal structure of complex constructs | Sorting and prioritizing measure dimensions from stakeholder input | Bridges qualitative and quantitative inquiry approaches |
| Delphi Method [2] | Achieve expert consensus on criteria priorities | Establishing relative weights for pragmatic measure dimensions | Iterative feedback process with structured communication |
| Abductive Analysis [1] | Analyze qualitative stakeholder data | Interpreting working group discussions and debates | Moves between empirical data and theoretical concepts |
| GRIPP2 Checklist [1] | Reporting stakeholder involvement | Ensuring comprehensive reporting of participatory research | Standardized reporting guideline for patient and public involvement |
Building on existing tools like PAPERS, we propose an expanded assessment framework that incorporates stakeholder perspectives across eight critical domains:
Each domain should be rated using a standardized scoring system that incorporates both expert assessment and stakeholder evaluation, with specific benchmarks for determining adequate performance across domains. This dual-perspective approach ensures that measures demonstrate both methodological rigor and practical utility.
Successful application of these methodologies requires attention to several practical considerations. First, stakeholder compensation must be adequate to ensure equitable participation, particularly for individuals with lived experience who may face financial barriers to engagement [1]. Second, accessibility of methodological materials is crucial, requiring the development of non-technical resources that explain complex concepts in understandable language without oversimplification [1]. Third, power dynamics in researcher-stakeholder relationships must be actively managed to ensure genuine partnership rather than tokenistic inclusion.
Implementation teams should establish clear protocols for documenting stakeholder contributions and ensuring that diverse perspectives are meaningfully incorporated rather than merely acknowledged. This includes creating mechanisms for resolving disagreements between stakeholder and researcher perspectives, with predetermined processes for balancing methodological requirements with practical considerations.
The expanded approach to pragmatic measure development introduces important ethical considerations. The principle of perspectivism recognizes that value judgments about what constitutes "pragmatic" are inherently subjective and may vary across different cultural and contextual settings [1]. This necessitates explicit attention to whose perspectives are included and how potential conflicts between different stakeholder viewpoints are reconciled.
Additionally, measures must be evaluated for their potential to perpetuate existing healthcare disparities through measurement bias that may disadvantage certain populations [1]. This requires critical examination of how fixed scales might embed assumptions that do not hold across diverse communities and developing approaches that maintain interpretive flexibility to mitigate such biases.
Moving beyond expert panels represents a necessary evolution in how implementation science conceptualizes and develops pragmatic measures. The methodologies and protocols presented here provide a structured approach for incorporating diverse stakeholder perspectives throughout the measure development process, addressing critical gaps in traditional approaches. By embracing more inclusive, participatory methods and balancing psychometric rigor with practical relevance, the field can develop measures that truly serve the needs of those implementing and experiencing healthcare interventions in real-world settings.
Future research should explore optimal strategies for balancing stakeholder perspectives with methodological requirements when tensions arise, develop more sophisticated approaches for assessing the pragmatic qualities of measures across diverse contexts, and establish benchmarks for determining when measures demonstrate sufficient pragmatism for widespread use. Additionally, investigation is needed into how to efficiently adapt existing measures with strong psychometric properties but limited pragmatism for enhanced usability in routine practice settings.
The foundational principle of pragmatism was first proposed by Charles Sanders Peirce in the 1870s as a method for clarifying concepts and meaning through their practical consequences [6]. The crux of Peirce's pragmatic maxim states: "Consider what effects, which might conceivably have practical bearings, we conceive the object of our conception to have. Then the whole of our conception of those effects is the whole of our conception of the object" [6]. This principle was originally developed as a tool to achieve the highest grade of conceptual clarity, moving beyond mere familiarity or definitional understanding to a comprehensive grasp of a concept's practical implications in real-world contexts [6].
Peirce identified three distinct grades of clarity for understanding concepts: (1) unreflective, everyday familiarity; (2) the ability to provide a general definition; and (3) understanding through the pragmatic maxim—knowing what practical effects to expect from holding that concept to be true [6]. For example, a complete understanding of "vinegar" requires not only recognizing it in daily experience and defining it as diluted acetic acid, but also deriving conditional expectations about its behavior, such as "if I dip litmus paper into it, it will turn red" [6]. This third grade of clarity forms the essence of Peirce's pragmatic method, transforming abstract concepts into testable, practical expectations.
Historical development reveals a significant divergence between Peirce's original methodological principle and later interpretations. Peirce remained dissatisfied with his early formulations and their subsequent development by fellow pragmatists, particularly William James and John Dewey [6] [7]. This dissatisfaction led him to rename his doctrine "pragmaticism" in later life—a term he explicitly designed to be "ugly enough to be safe from kidnappers" [7]. This deliberate rebranding distinguished his logically rigorous, scientifically-grounded approach from what he perceived as the more "nominalistic" and psychologically-oriented versions that had gained popularity [6].
The fundamental distinction lies in their respective conceptions of truth. For Peirce, truth represented "the ideal end of inquiry: that which would be agreed upon by all inquirers in the long run" within a "community of inquiry" [7]. This contrasted sharply with James's more individualistic and utilitarian interpretation, which emphasized "what works" for the particular believer [7]. Peirce maintained that his original pragmatic maxim served two crucial purposes: guiding scientific inquiry by highlighting which investigations would most impact the settled state of belief, and filtering out meaningless metaphysical statements that lacked practical bearings [6].
In modern implementation science, the pragmatic measures construct has been systematically operationalized through stakeholder-driven research. The Psychometric and Pragmatic Evidence Rating Scale (PAPERS) emerged from rigorous methodology including systematic literature reviews and extensive stakeholder engagement [8]. This work identified four conceptually distinct domains that comprise pragmatic measures: (1) Acceptable—measures that stakeholders find suitable and appropriate; (2) Compatible—measures that align with existing workflows and systems; (3) Easy—measures that are simple to implement and use; and (4) Useful—measures that provide valuable information for decision-making and practice [8].
Recent research emphasizes the critical importance of incorporating diverse stakeholder perspectives, including those with lived healthcare experience, when developing and evaluating pragmatic measures [1]. Stakeholders have expressed concerns about restricted definitions of pragmatism, potential biases in measurement, and the necessity for holistic, pluralistic approaches that acknowledge the complexity of human experience and the limitations of reducing multidimensional aspects of being human to clinical symptoms and measurement scales [1]. This expanded conceptualization moves beyond mere psychometric properties to embrace the dynamic social realities in which these measures are deployed.
Table 1: Evolution of Pragmatic Thought from Philosophical Principle to Implementation Science
| Aspect | Peirce's Original Pragmatism | Modern Implementation Science |
|---|---|---|
| Core Principle | Clarify meaning through practical consequences [6] | Enhance real-world applicability of research and measures [1] |
| Primary Method | Pragmatic maxim and three grades of clarity [6] | Stakeholder-driven framework development (e.g., PAPERS) [8] |
| Truth Basis | Ideal end of communal inquiry [7] | Practical, usable measures rooted in practice [1] |
| Key Applications | Scientific inquiry and metaphysical filtering [6] | Implementation strategies and healthcare improvement [1] [9] |
| Limitations Addressed | Meaningless metaphysical statements [6] | Restricted definitions and measurement biases [1] |
The pharmaceutical industry faces a significant implementation gap that pragmatism directly addresses. Recent studies indicate that approximately 50% of approved therapies achieve widespread adoption due to systemic barriers, creating a substantial "know-do" gap between discovery and delivery [9]. Evidence-based innovations take an average of 17 years to be incorporated into routine practice, with only half of proven interventions ever achieving broad uptake [9]. This adoption bottleneck represents not only a scientific challenge but also a practical one with real consequences: wasted resources, hindered patient impact, and exacerbated medical mistrust when inequities surface only after regulatory approval [9].
Implementation science offers a transformative lens for pharmaceutical companies by fundamentally reframing the core question from "Does this therapy work?" to "How can this therapy work best in real-world situations?" [9]. This shift in perspective is essential for identifying systemic and contextual factors that influence treatment success beyond traditional efficacy endpoints. For instance, glucagon-like peptide-1 (GLP-1) receptor agonists, while efficacious for diabetes and weight management, raise persistent practical questions about long-term adherence, equitable distribution systems, and the quantification of social perceptions affecting uptake [9]. Pragmatic approaches enable companies to address these implementation challenges proactively during development rather than reactively post-approval.
A layered planning approach effectively embeds implementation science throughout pharmaceutical development. This methodology incorporates implementation considerations at three distinct levels: (1) strategic brand or portfolio planning; (2) product-specific development plans; and (3) individual clinical trial designs [9]. By addressing real-world barriers and facilitators at each level, organizations can plan for implementation from the outset rather than attempting retrofitting late in development. This proactive stance allows for the identification of workflow challenges, adherence patterns, and practical needs that inform both trial design and health economic models, ensuring they reflect realistic scenarios rather than idealized assumptions [9].
Successful integration typically employs three core strategies: First, embedding structured frameworks to understand contextual factors influencing adoption; second, iterative planning that evolves strategies as new evidence emerges; and third, early collaboration with patients, providers, and payers to co-develop solutions reflecting their needs [9]. In some cases, hybrid trial designs that combine clinical effectiveness with implementation endpoints may be considered, though their complexity requires careful evaluation of feasibility within specific development programs [9]. The biosimilars implementation in oncology provides a compelling case study where hesitancy rooted in concerns about switching stable patients and limited real-world data was successfully addressed through stakeholder engagement, comprehensive education, and aligned organizational policies [9].
The business case for implementation science in pharmaceutical development is robust and multidimensional. Companies leveraging these approaches demonstrate measurable value across several domains: (1) accelerated adoption through early feedback loops that shorten the time from approval to widespread use; (2) improved outcomes by addressing adherence challenges during development; (3) enhanced trust through demonstrated commitment to real-world impact; and (4) reduced costs by proactively resolving implementation challenges before they become widespread problems [9]. This comprehensive value proposition extends beyond patient benefits to include significant advantages for healthcare systems and industry stakeholders.
Companies can begin integration through targeted pilots focused on specific challenges such as patient adherence or workflow optimization. These small-scale initiatives require modest financial commitments while generating valuable insights and building organizational confidence in the approach [9]. This incremental methodology allows implementation science to evolve into a core component of pharmaceutical development, ultimately ensuring that innovations not only reach the market but achieve optimal results across diverse populations and settings.
Table 2: Pharmaceutical Implementation Framework - Barriers and Pragmatic Solutions
| Development Phase | Common Implementation Barriers | Pragmatic Solutions | Stakeholder Engagement Focus |
|---|---|---|---|
| Early Clinical Development | Lack of real-world workflow considerations | Embed implementation endpoints in trial design [9] | Provider input on administration feasibility [9] |
| Late-Stage Trials | Limited understanding of adherence patterns | Hybrid designs testing implementation strategies [9] | Patient feedback on burden and acceptability [1] |
| Regulatory Submission | Insufficient data on contextual facilitators | Proactive collection of real-world implementation data [9] | Payer perspectives on evidence requirements [9] |
| Post-Market Phase | Variable uptake across healthcare settings | Tailored implementation kits based on barrier assessments [9] | Health system input on scalability and sustainability [8] |
Objective: To develop and validate pragmatic measures for implementation science research through systematic stakeholder engagement, ensuring the measures are acceptable, compatible, easy, and useful for end-users in real-world settings [8].
Background: Traditional implementation measures often fail to be adopted in community settings due to insufficient attention to pragmatic qualities. This protocol outlines a rigorous methodology for engaging diverse stakeholders throughout measure development, aligning with Peirce's pragmatic maxim by focusing on the practical consequences and usability of measurement instruments [6] [1].
Materials and Reagents:
Procedure:
Structured Stakeholder Engagement
Data Analysis and Interpretation
Concept Mapping and Criteria Validation
Delphi Consensus Process
Validation Methods:
Objective: To assess and enhance the implementation potential of pharmaceutical products during development by identifying and addressing real-world barriers to adoption, leveraging implementation science frameworks and stakeholder input.
Background: Pharmaceutical innovations frequently face adoption bottlenecks post-approval due to insufficient attention to implementation factors during development. This protocol provides a systematic approach for embedding implementation science throughout the pharmaceutical development lifecycle, aligning with Peirce's pragmatic emphasis on practical consequences [6] [9].
Materials and Reagents:
Procedure:
Late-Stage Implementation Preparation (Phase 3)
Pre-Launch Implementation Readiness (Registration Phase)
Post-Launch Implementation Optimization
Evaluation Metrics:
Table 3: Essential Research Reagents and Tools for Pragmatic Implementation Research
| Tool/Reagent | Function | Application Context | Key Features |
|---|---|---|---|
| PAPERS (Psychometric and Pragmatic Evidence Rating Scale) | Evaluates pragmatic qualities of implementation measures [8] | Measure development and selection | Assesses measures across four domains: Acceptable, Compatible, Easy, Useful [8] |
| Stakeholder Engagement Framework | Ensures diverse perspectives in measure development [1] | Participatory research design | Incorporates expertise by experience, uses accessible educational materials [1] |
| Concept Mapping Methodology | Organizes pragmatic criteria into conceptually distinct categories [8] | Measure development and refinement | Uses multidimensional scaling and hierarchical cluster analysis [8] |
| Abductive Analysis Approach | Iterative movement between data and theoretical concepts [1] | Qualitative data analysis | Creates codes through close reading of data and pragmatic philosophy [1] |
| Implementation Science Frameworks | Guides understanding of contextual factors influencing adoption [9] | Pharmaceutical implementation planning | Identifies barriers and facilitators across multiple levels [9] |
| Hybrid Trial Designs | Combines clinical effectiveness with implementation endpoints [9] | Clinical development optimization | Streamlines evidence generation for both efficacy and real-world implementation [9] |
| Barrier Assessment Tools | Systematically identifies obstacles to implementation [9] | Pre-implementation planning | Informs tailored implementation strategies [9] |
| GRIPP2 Reporting Checklist | Ensures quality reporting of stakeholder involvement [1] | Research documentation | Standardizes reporting of patient and public engagement [1] |
Engaging stakeholders in implementation research is critical for developing interventions and measures that are both scientifically rigorous and contextually relevant. This approach recognizes the pluralistic nature of value expectations across different stakeholder groups, which, if understood systematically, can significantly enhance the legitimacy and effectiveness of implementation efforts [10]. Research demonstrates that community-engaged implementation research contributes to greater community member empowerment, validates study findings, and increases community investment in successful implementation outcomes [11].
The conceptual foundation for this work rests on three core principles: First, it engages people with intimate knowledge of the setting in data collection or analysis. Second, it enhances the validity of data and its interpretation through multiple observers and data sources. Third, it empowers participants by giving them agency and investment in implementation success [11]. When these principles are operationalized effectively, implementation strategies can address the diverse, and sometimes competing, value expectations that different stakeholders bring to the research process.
Empirical research has identified distinct value expectations across different stakeholder groups, highlighting the necessity of methodological approaches that can capture this pluralism [10]. Understanding these diverse perspectives is essential for designing implementation strategies that resonate with all involved parties.
Table: Documented Value Expectations Across Stakeholder Groups
| Stakeholder Group | Primary Value Expectations | Implementation Focus |
|---|---|---|
| Government/Policy Actors | Process integrity, mandate fulfillment, decision-making integration [10] | System-level integration, policy alignment |
| Industry/Healthcare Providers | Cost-effectiveness, implementation efficiency, procedural certainty [10] | Resource optimization, workflow compatibility |
| Conservation/Technical Groups | Data quality, technical robustness, methodological rigor [10] | Evidence quality, analytical soundness |
| Interested & Affected Parties (IAPs) | Local context issues, immediate relevance, accessibility [10] | Local impact, contextual appropriateness |
A case study of strategic environmental assessment demonstrated that while all stakeholder groups shared some common value expectations, each group maintained distinct priorities that reflected their organizational roles and responsibilities [10]. This pluralism necessitates implementation approaches that are flexible enough to accommodate diverse definitions of success while maintaining methodological rigor.
Concept mapping is a structured conceptualization process that yields a conceptual framework for how a group views a particular topic [11]. This method is particularly valuable for engaging diverse stakeholders in identifying and prioritizing implementation strategies, as it combines qualitative group processes with quantitative analytical techniques to represent relationships between ideas visually.
Table: Research Reagent Solutions for Concept Mapping
| Item | Function | Implementation Example |
|---|---|---|
| Groupwisdom Software | Analyzes sort and rating data; generates visual concept maps [11] | Creates weighted cluster maps, ladder graphs, and go-zone maps |
| Structured Focus Group Guide | Guides interpretation sessions for preliminary findings [11] | Facilitates discussion on cluster meaningfulness and strategy prioritization |
| Participant Recruitment Framework | Ensures diverse stakeholder representation [11] | Engages clinic members, providers, community advocates, and policymakers |
| Rating and Sorting Materials | Captures stakeholder perspectives on meaning, importance, and feasibility [11] | Uses 4-point scales for importance/feasibility and pile sorting tasks |
The protocol follows six sequential steps [11]:
Methodological pluralism applies multiple methodologies and epistemological stances to build a more complete understanding of complex interventions [12]. This approach is particularly valuable for capturing the pluralistic needs of diverse stakeholders, as it redresses the limitations inherent in any single method and provides a more holistic and textured analysis.
Table: Research Reagent Solutions for Methodological Pluralism
| Item | Function | Implementation Example |
|---|---|---|
| Developmental Evaluation Framework | Supports real-time feedback and adaptation in complex initiatives [12] | Tracks emergent outcomes and informs iterative strategy adjustments |
| Principles-Focused Evaluation Guide | Assesses adherence to guiding principles in dynamic environments [12] | Evaluates implementation against established community engagement principles |
| Network Analysis Tools | Maps and measures collaboration patterns and relationships [12] | Quantifies changes in stakeholder connections and knowledge exchange |
| Framework Analysis Methodology | Provides systematic thematic analysis of qualitative data [12] | Identifies recurring themes across different stakeholder perspectives |
This protocol employs four complementary evaluation approaches simultaneously [12]:
Systematic measurement of stakeholder engagement is essential for assessing implementation success. The Implementation Science Center for Cancer Control Equity operationalized the 9 Principles of Community Engagement and developed corresponding survey questions to evaluate their partnership with Community Health Centers (CHCs) [13]. Of 38 respondents (64.4% response rate), most perceived their engagement positively, with over 92% feeling respected by academic collaborators and perceiving projects as beneficial [13]. This systematic approach to measuring engagement quality provides a model for evaluating the operationalization of community engagement principles in implementation research.
The development of psychometrically and pragmatically strong measures is critical for advancing implementation science. The Psychometric and Pragmatic Evidence Rating Scale (PAPERS) was developed through stakeholder-driven research to evaluate implementation measures across four key categories [14]:
This framework emphasizes that for implementation measures to be used in real-world settings, they must not only be psychometrically sound but also practical and acceptable to diverse stakeholders, including those with lived experience of the implementation context.
Implementation outcome measurement presents particular challenges in complex healthcare settings like Paediatric Intensive Care Units (PICU), where validated instruments are scarce [15]. A systematic review of implementation outcome measures found that most instruments had limited evidence of validity or reliability and demonstrated poor psychometric properties [15]. This measurement gap highlights the urgent need for pragmatic measures that can capture implementation outcomes across diverse contexts while accommodating the pluralistic needs of various stakeholders. Engaging stakeholders in the development and validation of these measures is essential for ensuring their utility in complex real-world settings.
This document provides application notes and protocols for developing pragmatic measures in implementation science research. The framework is designed to help researchers bridge the gap between abstract theoretical constructs and concrete, stakeholder-valued outcomes, facilitating the systematic evaluation of implementation strategies.
The following table summarizes the core constructs, their operational definitions, and corresponding quantitative metrics for assessing implementation outcomes. [16] [17]
| Core Construct | Operational Definition | Quantitative Metric(s) | Data Collection Method |
|---|---|---|---|
| Feasibility | The extent to which an implementation strategy can be successfully used or carried out within a given setting. | Percentage of protocol components executed as planned; Provider-reported ease-of-use scale (1-5). | Facilitated session notes; Post-implementation survey. |
| Adoption | The intention, initial decision, or action to try or employ an innovation or implementation strategy. | Rate of uptake (proportion of clinicians using the strategy); Time to initial adoption. | Administrative data; Key informant interviews. |
| Fidelity | The degree to which an implementation strategy was implemented as defined in the original protocol. | Adherence score (% of core components delivered); Competence rating (independent assessor, 1-7 scale). | Direct observation; Session audio recording review. |
| Implementation Cost | The financial impact of the implementation effort from the health system perspective. | Total cost; Cost per patient reached; Incremental cost-effectiveness ratio (ICER). | Time-motion studies; Micro-costing from administrative records. |
| Penetration | The integration of a practice within a service setting and its subsystems. | Proportion of eligible settings using the strategy; Proportion of eligible patients receiving the innovation. | Organizational report; Patient-level administrative data. |
| Sustainability | The extent to which a newly implemented treatment is maintained or institutionalized within a service setting’s ongoing, stable operations. | Continuation of service delivery 12+ months post-implementation; Level of institutional funding support. | Longitudinal follow-up survey; Budget analysis. |
Essential materials and tools for conducting implementation science research on pragmatic measures. [16] [17]
| Item | Function in Research |
|---|---|
| Standard Protocol Template (SPIRIT 2025) | Provides a structured checklist of 34 minimum items to ensure trial protocol completeness, covering planning, conduct, and reporting. [16] |
| Implementation Outcomes Kit (Proctor Model) | A conceptual framework defining eight key implementation outcomes (acceptability, adoption, etc.) to guide measurement selection. |
| Stakeholder Engagement Matrix | A tool to map key stakeholders (patients, providers, policymakers) and plan their involvement in design, conduct, and reporting. [16] |
| Data Visualization Software (e.g., Tableau) | Enables analysis of structured data (rows and columns) to understand aggregation, granularity, and distributions for key metrics. [18] |
| Qualitative Data Analysis Software (e.g., NVivo) | Facilitates the coding and thematic analysis of interview and focus group data to contextualize quantitative findings. |
Objective: To quantitatively assess the degree to which an evidence-based practice is delivered as originally prescribed.
Background: Fidelity measurement is critical for distinguishing between ineffective interventions and ineffective implementation. [16]
Materials:
Methodology:
Objective: To involve patients and the public in the design and validation of pragmatic outcome measures.
Background: Patient and public involvement ensures that developed measures are relevant and meaningful to end-users. [16]
Materials:
Methodology:
This document outlines the application of implementation science principles to develop a pragmatic framework for campus sexual violence interventions. The approach emphasizes stakeholder engagement and adaptive strategies to bridge the gap between research and real-world application, addressing a critical public health issue.
Current data reveals significant disparities between sexual violence prevalence and official reporting rates, highlighting a critical implementation gap. The following table summarizes key quantitative findings from recent campus surveys.
Table 1: Quantitative Data on Campus Sexual Violence and Reporting (2024-2025)
| Metric | UVA Findings | Harvard Findings | General Population Notes |
|---|---|---|---|
| Sexual Harassment (Undergraduate Women) | 26% (down from 29% in 2019) [19] | Reported decline (specific % not detailed) [19] | Consistent with national trends |
| Sexual Harassment (Graduate Women) | 13.7% (down from 22.8% in 2019) [19] | Reported decline (specific % not detailed) [19] | |
| Harassment in Non-binary/Transgender Students | 29.3% (Graduate) [19] | Elevated rates acknowledged [19] | 47.1% in a 10-university consortium [19] |
| Student Awareness of Reporting Procedures | 64% [19] | Majority aware, but reporting rates low [19] | Indicates a knowledge-to-action gap |
| Incidents Formally Reported by Victims | <30% [19] | Minority reported [19] | Major barrier to intervention and support |
| Primary Reasons for Non-Reporting | Fear of retaliation, distrust of institutional response, belief that reporting is futile [19] | Similar trust and efficacy concerns [19] | Points to systemic implementation failures |
Objective: To collaboratively adapt evidence-based interventions (EBIs) to fit the specific cultural, social, and structural context of a university campus, leveraging stakeholder input.
Background: Standardized interventions often fail due to a lack of contextual fit. This protocol facilitates a participatory process with key campus groups to enhance acceptability and feasibility [19].
Materials:
Procedure:
Outputs:
Objective: To evaluate the real-world effectiveness and implementation outcomes of the co-designed intervention across multiple campuses.
Background: A stepped-wedge cluster randomized trial (SW-CRT) design allows all participating sites to eventually receive the intervention, which is often ethically and logistically preferable in campus settings [19].
Materials:
Procedure:
Analysis:
The following diagram illustrates the multi-level, iterative logic of the stakeholder-informed implementation framework.
This section details key "reagents"—the essential measurement tools and materials—required for rigorous implementation research in this field.
Table 2: Essential Research Reagents for Implementation Science in Campus Sexual Violence
| Research Reagent | Type / Format | Primary Function in Research |
|---|---|---|
| Campus Climate Survey | Validated Quantitative Instrument | To establish baseline and follow-up measures of prevalence, awareness, attitudes, and reporting intentions across the student population [19]. |
| Implementation Fidelity Checklist | Observer-Rated Protocol | To ensure the adapted intervention is delivered as intended across different campuses and facilitators, measuring adherence to the core protocol. |
| Stakeholder Engagement Assessment | Mixed-Methods Survey & Interview Guide | To evaluate the process and quality of stakeholder collaboration, assessing factors like representativeness, influence, and satisfaction. |
| Title IX Policy Database | Systematic Document Coding Framework | To track and analyze variations in institutional policies and their alignment with federal guidelines, enabling analysis of policy impact [19]. |
| Bystander Efficacy Scale | Validated Psychometric Scale | To measure changes in participants' confidence and intention to intervene safely in situations perceived as high-risk for sexual violence [19]. |
| Resource Utilization Log | Standardized Tracking Sheet | To quantitatively monitor the cost and consumption of support resources (e.g., counseling sessions, advocacy hours), informing economic and feasibility analyses [19]. |
Case study research is an indispensable methodology for achieving a deep, contextual understanding of implementation processes in complex, real-world settings. This approach allows for in-depth, multi-faceted explorations of complex issues precisely within their natural contexts, making it particularly valuable for investigating the "how" and "why" behind implementation successes and failures [20]. Within the broader thesis of developing pragmatic measures for implementation science, case studies provide the rich, contextual data necessary to ensure that these measures are not only scientifically valid but also practically applicable across diverse settings, including the specialized field of drug development.
The fundamental value of the case study approach lies in its ability to capture the complex interplay between interventions, their implementation contexts, and the resulting outcomes. As noted in methodological literature, case studies are particularly useful "to investigate contemporary phenomena within its real-life context," especially "when the boundaries between phenomenon and context are not clearly evident" [20]. This characteristic makes case studies exceptionally well-suited for implementation science, where the context is often inseparable from the implementation success itself. For drug development professionals and researchers, this methodology offers a structured approach to understanding why certain interventions thrive in specific environments while others fail, thereby informing more effective implementation strategies.
Case study research aligns with several epistemological traditions, including constructivist paradigms that emphasize multiple realities and interpretive approaches that seek to understand phenomena through the meanings people assign to them. This methodological flexibility allows researchers to tailor their approach based on the specific implementation questions being investigated. The case study approach is particularly appropriate for addressing specific types of research questions, including those that seek to explore complex interventions where the pathways from intervention to effects are not straightforward, and those that investigate implementation contexts where the intervention and context are intrinsically linked [20].
When designing case study research for implementation science, several key considerations emerge. First, researchers must clearly define the "case" itself—whether it be a specific implementation project, an organizational process, or a particular intervention rollout. Second, the unit of analysis must be carefully specified, as this determines the boundaries of data collection and analysis. Third, the theoretical underpinnings should guide the design, selection, conduct, and interpretation of case studies to ensure methodological rigor [20]. These considerations are essential for producing findings that contribute meaningfully to developing pragmatic measures that are both scientifically sound and practically applicable.
Multiple-case designs are particularly valuable in implementation science as they allow for comparisons across different contexts, revealing both common and unique factors influencing implementation. For instance, a study examining workforce reconfiguration in respiratory services employed a multiple-case design across four Primary Care Organizations, enabling researchers to identify how local contexts influenced the implementation process [20]. Similarly, research on campus sexual violence interventions developed an adapted implementation science framework through four case studies from the United States, South Africa, and Eswatini, revealing cross-cutting issues unique to this implementation context [21].
These comparative approaches allow researchers to distinguish between context-specific factors and those that transcend settings, a crucial consideration when developing pragmatic measures intended for broad application. The replication logic—where each case is selected to predict similar results (literal replication) or produce contrasting results for predictable reasons (theoretical replication)—strengthens the theoretical foundations of implementation science and contributes to more robust, context-sensitive measures [20].
Case study research in implementation science typically employs multiple data sources to develop a comprehensive understanding of the phenomenon under investigation. Common data collection methods include semi-structured interviews, document analysis, field observations, and increasingly, quantitative metrics that complement qualitative insights [20]. This methodological triangulation enhances the validity of findings by providing multiple perspectives on implementation processes.
For example, a mixed methods, longitudinal, multi-site case study of electronic health record implementation in England's NHS collected data through "semi-structured interviews, documentary data and field notes, observations and quantitative data" [20]. This comprehensive approach allowed researchers to capture both the technical and social aspects of implementation across different hospital contexts. Similarly, research on patient safety education employed a multi-site, mixed method collective case study across eight educational sites, collecting data through "documentary evidence, complemented with a range of views and observations" across different contexts [20].
Table 1: Data Sources for Case Study Research in Implementation Science
| Data Source | Application in Implementation Science | Considerations for Pragmatic Measures |
|---|---|---|
| Semi-structured interviews | Capture stakeholder experiences, barriers, and facilitators | Ensure interview guides align with implementation outcomes of interest |
| Documentary analysis | Review implementation plans, meeting minutes, policies | Provides insight into formal vs. informal implementation processes |
| Field observations | Witness implementation in real-time | Captures behaviors and interactions that may not be reported in interviews |
| Quantitative metrics | Track implementation reach, fidelity, and outcomes | Enables mixed-method analysis and pattern identification |
The analysis of case study data in implementation science often employs both deductive and inductive approaches, frequently guided by established implementation frameworks while remaining open to emergent themes. For instance, the Consolidated Framework for Implementation Research (CFIR) provides a comprehensive "overarching typology to promote implementation theory development and verification about what works where and why across multiple contexts" [22]. This framework identifies five major domains—intervention characteristics, outer context, inner context, characteristics of individuals, and process—that guide the consideration and assessment of factors which might impact implementation.
Analysis frequently involves coding data according to predetermined frameworks while allowing for emergent themes. For example, one study analyzed qualitative data "thematically using a socio-technical coding matrix, combined with additional themes that emerged from the data" [20]. This balanced approach ensures that analysis captures both anticipated and unanticipated insights about implementation processes, contributing to more comprehensive pragmatic measures.
Purpose: To identify contextual factors influencing implementation success across multiple sites and develop context-sensitive pragmatic measures.
Methodology:
Adaptation for Drug Development Contexts: In pharmaceutical settings, this protocol can be adapted to study implementation of new research methodologies, quality initiatives, or regulatory processes across different research sites, therapeutic areas, or geographic locations.
Purpose: To document and analyze implementation processes over time, capturing adaptations and evolving contextual influences.
Methodology:
This approach aligns with the "longitudinal, multi-site, socio-technical collective case study" employed in research on electronic health record implementation [20], which tracked implementation efforts over time to understand evolving challenges and adaptations.
Case study research has proven particularly valuable for adapting and developing implementation frameworks to address specific contexts or content areas. For instance, research on campus sexual violence interventions used a multiple case study approach to identify "multiple cross-cutting issues unique to the IS of campus sexual violence interventions: policy and legal framework, team praxis, relationships, context, infrastructure, and people" [21]. These insights led to the development of "an adapted CFIR framework... from a cross-national set of case studies" that better addressed the unique needs of this implementation context [21].
Similarly, the ISAC Match process was developed through case study work to provide "expanded guidance and potential approaches" for selecting and tailoring implementation strategies in community settings [23]. This process includes four steps: "1) reviewing available information on EBI integration and conducting contextual inquiry, if needed, to understand barriers and facilitators; 2) identifying existing implementation strategies used in the practice setting, 3) using recommended guidance tools to select relevant implementation strategies to overcome barriers and capitalize on facilitators; and 4) tailoring strategies to fit within the setting" [23].
Case studies provide invaluable insights for selecting and tailoring implementation strategies to address context-specific barriers and leverage facilitators. The ISAC Match process, developed specifically for community settings, employs a "strength-based approach (i.e., considering both barriers and facilitators) in the decision-making process" [23]. This approach recognizes that effective implementation requires not only addressing barriers but also capitalizing on existing strengths and facilitators.
Table 2: Implementation Outcomes for Case Study Evaluation
| Implementation Outcome | Definition | Assessment Approach |
|---|---|---|
| Acceptability | Perception among stakeholders that an intervention is agreeable | Interviews, surveys assessing satisfaction and comfort |
| Adoption | Intention or initial decision to employ an intervention | Documentation of uptake, interviews regarding adoption decisions |
| Appropriateness | Perceived fit or relevance of an intervention for a given setting | Interviews assessing perceived relevance and fit |
| Fidelity | Degree to which an intervention is implemented as intended | Observational measures, self-report checklists |
| Coverage | Reach of the intervention within the target population | Utilization data, participation records |
| Sustainability | Extent to which an intervention is maintained or institutionalized | Long-term follow-up, organizational integration assessment |
Implementation scientists conducting case study research benefit from a structured set of conceptual and methodological tools. These resources ensure methodological rigor while maintaining the flexibility needed to capture rich, contextual insights about implementation processes.
Table 3: Research Reagent Solutions for Implementation Case Studies
| Tool Category | Specific Tools/Resources | Function in Case Study Research |
|---|---|---|
| Conceptual Frameworks | CFIR, TDF, RE-AIM, ISAC | Provide theoretical grounding and guide data collection and analysis |
| Data Collection Tools | Semi-structured interview guides, observation protocols, document abstraction tools | Standardize data collection while allowing emergence of context-specific insights |
| Analytical Tools | Framework analysis guides, qualitative coding software, pattern-matching templates | Support systematic analysis of complex, multi-source data |
| Reporting Guidelines | CASE, COREO, SCRIB | Enhance transparency and completeness of case study reporting |
The "Implementation research toolkit" developed by TDR provides additional resources specifically designed for implementation research, including modules on "Understanding IR, Integrating IR into the health system, IR-related communications and advocacy and Intersectional gender lens" [24]. These resources support researchers in conducting rigorous, ethically sound case study research that generates actionable insights for improving implementation in real-world settings.
Case study research offers implementation scientists a powerful methodology for developing the deep, contextual understanding necessary to create pragmatic measures that resonate with real-world complexities. By systematically studying implementation phenomena within their natural contexts, researchers can identify the nuanced factors that determine success or failure, document the adaptations that make interventions workable in diverse settings, and develop frameworks that genuinely support effective implementation.
For drug development professionals and implementation researchers, the rigorous application of case study methods provides an evidence base for improving implementation processes, selecting and tailoring implementation strategies, and ultimately enhancing the impact of evidence-based interventions across diverse contexts. As implementation science continues to evolve, case study research will remain an essential approach for ensuring that our implementation theories, frameworks, and measures maintain their relevance and utility in addressing the complex challenges of real-world implementation.
The Implementation Strategies Applied in Communities Match process (ISAC Match) is a pragmatic, systematic approach designed to address a critical gap in implementation science: the selection and tailoring of implementation strategies for community (non-clinical) settings [23]. Implementation strategies are defined as methods or techniques to improve the adoption, implementation, sustainment, and scale-up of evidence-based interventions (EBIs) [23] [25]. The ISAC Match process was developed in response to the limitations of existing compilations and matching processes, such as the Expert Recommendations for Implementing Change (ERIC), which were developed in clinical settings and often use clinical terminology that is difficult to apply in community contexts [23] [25]. This process provides a structured yet flexible framework for researchers and practitioners working in integrated research-practice partnerships to identify and adapt strategies that overcome implementation barriers and capitalize on facilitators, with explicit consideration of health equity to ensure strategies narrow rather than widen existing health disparities [23].
The ISAC Match process is designed to be applied within integrated research-practice partnerships (IRPPs) or similar collaborative models that equally value researcher and practitioner contributions [23]. Before initiating the process, participants must have identified a specific evidence-based intervention for integration and possess the organizational authority to influence its implementation [23]. The process unfolds through four sequential but iterative steps, each requiring collaborative engagement between research and practice partners to ensure selected strategies are both evidence-informed and contextually appropriate.
The following workflow diagram visualizes the core ISAC Match process and its relationship to the broader implementation cycle:
Objective: To understand implementation barriers and facilitators through rapid assessment methods.
Materials Needed: Existing literature on EBI integration, interview/focus group guides, recording equipment, qualitative analysis software (optional), prioritization tools (e.g., card sort materials, 2x2 grid poster board).
Procedure:
Output: A prioritized list of implementation barriers and facilitators to inform strategy selection.
Objective: To document implementation strategies already in use within the organization.
Materials Needed: Organizational documents (program guides, implementation blueprints), meeting space, recording equipment.
Procedure:
Output: An inventory of existing implementation strategies and organizational supports.
Objective: To select new implementation strategies from the ISAC compilation to address prioritized barriers and leverage facilitators.
Materials Needed: ISAC guidance tools (Barrier-Level Tool and RE-AIM Framework Tool), ISAC compilation list, prioritized barriers/facilitators from Step 1.
Procedure:
Output: A long list of potential new implementation strategies matched to prioritized barriers.
Objective: To adapt selected implementation strategies to fit the local context.
Materials Needed: List of selected strategies from Step 3, tailoring worksheet.
Procedure:
Output: A set of fully specified, tailored implementation strategies with a detailed implementation plan.
The development of the ISAC compilation and matching process was informed by qualitative research with 18 researchers and practitioners across diverse community settings. The following table summarizes the most frequently mentioned implementation strategies identified through this research, providing insight into strategies commonly employed in community settings.
Table 1: Frequently Mentioned Implementation Strategies in Community Settings
| Implementation Strategy | Frequency Mentioned (n=18) | Primary RE-AIM Dimensions Addressed |
|---|---|---|
| Conduct Pragmatic Evaluation | 31 | Implementation, Maintenance |
| Provide Training | 26 | Adoption, Implementation |
| Change Adaptable Program Components | 26 | Implementation, Effectiveness |
| Leverage Funding Sources | 21 | Adoption, Maintenance |
| Develop Implementation Blueprints | 19 | Implementation, Maintenance |
| Tailor Strategies for Priority Populations | 18 | Reach, Effectiveness |
| Build Community Coalitions | 17 | Adoption, Reach |
| Provide Technical Assistance | 16 | Implementation, Maintenance |
| Facilitate Shared Learning | 15 | Adoption, Implementation |
| Create Program Guides | 14 | Implementation, Maintenance |
Source: Adapted from Balis et al. (2024), International Journal of Behavioral Nutrition and Physical Activity [25]
Table 2: Essential Research Reagents for ISAC Match Application
| Research Reagent / Tool | Function / Application in ISAC Match |
|---|---|
| ISAC Compilation | A comprehensive list of 40 implementation strategies specifically used in community settings, with definitions and examples for each [26] [25]. |
| Barrier-Level Guidance Tool | Enables matching of implementation strategies to barriers at different levels of influence: individual, innovation, inner setting, outer setting/external environment, and implementation process [26]. |
| RE-AIM Framework Tool | Facilitates selection of implementation strategies based on challenges related to specific RE-AIM framework dimensions: Reach, Effectiveness, Adoption, Implementation, and Maintenance [26]. |
| CFIR Interview Guide | A structured guide based on the Consolidated Framework for Implementation Research to systematically assess implementation determinants during contextual inquiry [23]. |
| Card Sort Materials | Physical or digital cards used for prioritizing barriers and strategies through collaborative sorting activities with stakeholders [23]. |
| Implementation Blueprints | Templates for creating detailed specifications of how evidence-based interventions should be implemented, including core components and adaptable elements [25]. |
| Pragmatic Evaluation Tools | Simplified measurement instruments designed to assess implementation outcomes without creating excessive burden in resource-constrained community settings [25]. |
The utility of ISAC Match is demonstrated in a case study involving Montana State University Extension Agents, who sought to increase adoption of built environment approaches to facilitate physical activity [23] [27]. The process was applied within an integrated research-practice partnership that included both researchers and extension professionals. Through the four-step process, the partnership identified key barriers including limited technical expertise in built environment strategies, competing demands on agent time, and varying community resources across implementation sites [23]. Existing strategies were documented, including standard training sessions and program guides. Using ISAC guidance tools, the partnership selected additional strategies including "develop implementation blueprints," "provide technical assistance," and "facilitate shared learning" [23]. These strategies were then tailored to fit the extension context by developing role-specific implementation resources, creating a peer-mentoring program between experienced and novice agents, and establishing a community of practice for ongoing support [23]. This case exemplifies how ISAC Match provides a structured yet flexible approach to addressing implementation challenges in community settings.
In implementation science, the deliberate alteration of evidence-based interventions (EBIs) and implementation strategies is often necessary to improve their fit and effectiveness in new contexts [28]. However, ad-hoc modifications pose significant challenges for reproducibility, scientific rigor, and understanding the mechanisms of implementation success. The Framework for Reporting Adaptations and Modifications-Enhanced (FRAME) and the Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies (FRAME-IS) address this gap by providing systematic approaches for documenting modifications [29] [28]. These frameworks are particularly valuable for developing pragmatic measures in implementation research, offering structured methodologies to capture the complex reality of adaptation while maintaining scientific rigor.
The FRAME was initially developed to track modifications to clinical and psychosocial interventions, while the FRAME-IS extends this structure to document changes to the implementation strategies themselves—the methods and techniques used to adopt, implement, and sustain EBIs in routine practice [29]. This distinction is critical because implementation strategies range from relatively "light touches" (e.g., audit and feedback) to more intensive, multicomponent strategies that may act on multiple levels of a health system [29]. Documenting adaptations to both the intervention and implementation strategy provides a comprehensive understanding of how and why changes occur throughout the implementation process.
Both FRAME and FRAME-IS employ a modular architecture that combines core (required) and supplementary (optional) components to balance comprehensiveness with practical utility across diverse implementation projects [29] [30]. This structure allows researchers to document essential elements while providing flexibility to capture context-specific details relevant to their particular study aims and resources.
The FRAME-IS consists of seven modules that guide users in characterizing various aspects of modifications [29] [30]. Core modules capture fundamental information including a brief description of the EBP, implementation strategy, and modifications (Module 1); what is modified (Module 2); the nature of the modification (Module 3); and the rationale for the modification (Module 4) [29]. Supplementary modules document when the modification occurred and whether it was planned (Module 5); who participated in the decision to modify (Module 6); and how widespread the modification is (Module 7) [29]. This systematic approach ensures consistent documentation across studies and settings, enabling comparative analysis of adaptation patterns.
Table: Core and Supplementary Modules in FRAME-IS
| Module Type | Module Name | Key Elements Documented | Item Count |
|---|---|---|---|
| Core | Module 1: Brief Description | EBP, implementation strategy, modifications | 4 items |
| Core | Module 2: What is Modified? | Specific components or elements changed | 9 items |
| Core | Module 3: Nature of Modification | Content, context, or training changes | 18 items |
| Core | Module 4: Rationale for Modification | Reasons and goals for adaptation | 15 items |
| Supplementary | Module 5: Timing and Planning | When modification occurs, planned/unplanned | 9 items |
| Supplementary | Module 6: Decision Participants | Stakeholders involved in adaptation decisions | 10 items |
| Supplementary | Module 7: Reach and Scope | How widespread the modification is | 9 items |
Table: Quantitative Overview of FRAME-IS Instrument
| Characteristic | Specification |
|---|---|
| Total Items | 75 |
| Instrument Type | Survey |
| Data Collection Method | Quantitative |
| Cost | Free |
| Expertise Required for Interpretation | Yes |
| Training Required | Yes |
| Equity-Relevant Components | Included |
When time and resources are limited, or when a large number of adaptations have been made, researchers can focus on seven key aspects of adaptations that provide the most critical information for understanding their potential impact [28]. These include: (1) what specifically was adapted (e.g., which activities or components of the protocol); (2) the focus (e.g., the intervention, implementation strategies, or context); (3) the purpose of the adaptation (e.g., to enhance reach, improve equity, increase fidelity); (4) the timing and sequence of adaptations; (5) whether the adaptation was bundled with other adaptations; (6) the scope and frequency of exposure to adaptations; and (7) whether the adaptation was planned or made in response to emerging events [28].
Documenting whether modifications are fidelity-consistent is particularly important for understanding their relationship to core elements or functions of the original intervention or implementation strategy [29]. This distinction helps researchers and practitioners determine whether adaptations preserve the essential, theoretically-grounded components of an evidence-based approach while modifying more peripheral elements to improve contextual fit.
Purpose: To systematically document planned and unplanned adaptations to both the intervention and implementation strategies during clinical trials or implementation studies.
Materials Required: FRAME-IS documentation tool [30], data collection platform (electronic or paper-based), stakeholder roster, implementation strategy specification template.
Procedural Steps:
Quality Control: Cross-verify adaptation documentation through multiple methods including team meeting minutes, stakeholder interviews, and implementation team logs. Conduct periodic audits to ensure consistent application of FRAME-IS categories across team members.
Purpose: To identify and characterize adaptations that occurred during completed implementation projects through retrospective analysis.
Materials Required: Project documentation (meeting minutes, progress reports, implementation logs), interview/focus group guides, FRAME-IS coding template [30], qualitative data analysis software.
Procedural Steps:
Analytical Considerations: When numerous adaptations are identified, prioritize analysis on those affecting core functions of interventions or implementation strategies rather than peripheral elements [28]. Consider using mixed methods approaches by quantitatively characterizing adaptation frequency and types while qualitatively exploring rationales and decision-making processes [31].
To advance the science of adaptation, documented modifications must be systematically linked to implementation outcomes. The Model for Adaptation Design and Impact (MADI) provides a useful framework for creating explanatory models that connect adaptations to outcomes through hypothesized mechanisms [28]. This approach enables researchers to move beyond simply documenting what changed to understanding how and why adaptations influence implementation success.
When designing studies to assess adaptation impact, researchers should identify both proximal and distal outcomes of adaptations [28]. Proximal outcomes are immediate effects such as changes in acceptability, appropriateness, or feasibility perceptions. Distal outcomes occur later in the implementation process and may include measures of fidelity, penetration, or sustainability. Explicitly specifying the expected pathways from adaptation to outcomes helps focus measurement efforts on the most relevant constructs and timepoints.
Table: Adaptation Impact Assessment Framework
| Outcome Category | Example Measures | Typical Timing | Data Collection Methods |
|---|---|---|---|
| Proximal Outcomes | Acceptability of adapted intervention, Perceived appropriateness, Feasibility ratings | Immediate to short-term | Surveys, interviews, focus groups |
| Implementation Outcomes | Fidelity, Adoption, Penetration, Cost | Short to medium-term | Administrative data, observation, cost tracking |
| Service Outcomes | Efficiency, Safety, Effectiveness, Equity | Medium to long-term | Service records, clinical data, patient reports |
| Patient Outcomes | Symptom improvement, Functional status, Quality of life, Satisfaction | Long-term | Clinical assessments, patient-reported outcomes |
Recent methodological recommendations provide guidance for designing rigorous studies to assess the impact of adaptations on implementation outcomes [28]. Four key recommendations include:
These recommendations emphasize that while experimental designs are often regarded as the gold standard, various study designs including descriptive and correlational approaches can provide valuable insights into adaptation impacts, particularly when implemented with careful attention to measurement and causal inference.
Table: Essential Methodological Tools for Adaptation Research
| Research Reagent | Function | Application Context |
|---|---|---|
| FRAME-IS Documentation Tool | Standardized instrument for tracking modifications to implementation strategies | Prospective tracking or retrospective analysis of implementation strategy adaptations |
| Adaptation Tracking Protocol | Step-by-step procedures for identifying and documenting adaptations | Integration into implementation trial protocols or quality improvement initiatives |
| Stakeholder Engagement Guide | Structured approach for involving diverse perspectives in adaptation decisions | Ensuring community and practitioner input in adaptation processes |
| Mixed Methods Integration Framework | Approaches for connecting quantitative and qualitative adaptation data | Comprehensive understanding of adaptation patterns and rationales [31] |
| Implementation Strategy Specification Templates | Tools for explicitly describing implementation strategies before adaptation | Establishing baseline for comparing pre- and post-adaptation strategies [29] |
| Adaptation-Outcome Linking Matrix | Framework for hypothesizing and testing relationships between adaptations and outcomes | Designing studies to examine adaptation impact on implementation outcomes [28] |
The FRAME and FRAME-IS frameworks provide implementation researchers and drug development professionals with systematic approaches for documenting modifications to both interventions and implementation strategies. By applying these structured protocols, researchers can advance the field's understanding of how, when, and why adaptations occur, and their relationship with implementation outcomes. As implementation science continues to develop more pragmatic measures, systematic adaptation tracking will play an increasingly important role in bridging the gap between evidence-based interventions and real-world implementation success.
Integrated Research-Practice Partnerships (IRPPs) represent a transformative approach to implementation science by moving beyond traditional linear translation models toward collaborative systems that integrate scientific evidence with practice-based expertise. These partnerships are defined as long-term collaborations between researchers and practitioners/policymakers designed to improve outcomes through sustained collaboration and mutual commitment to systems-level problem-solving [32]. The fundamental premise of IRPPs is that integrating scientific and community/clinical systems to address scientifically innovative questions with practical implications increases the likelihood of both sustained implementation and generating replicable evidence of generalizability across systems [33].
IRPPs differ fundamentally from traditional pipeline models, which typically follow a sequential efficacy-effectiveness-dissemination pathway. Traditional models often struggle with translation because they [34]:
In contrast, IRPPs employ iterative, interactive processes for decision-making that value both research evidence and practitioner expertise, ultimately leading to interventions that are more practical, effective, and sustainable [33] [34].
The IRPP framework operates on several foundational propositions that distinguish it from traditional research translation models [33]:
Integration Proposition: Combining scientific and community/clinical systems addresses both scientific innovation and practical needs, enhancing sustained implementation and evidence generalizability
Systems Approach Proposition: Sustainable interventions require both vertical (staff to decision-makers) and horizontal (cross-sector) system engagement
Principles-Focused Proposition: Research synthesis concentrating on evidence-based principles rather than prescribed products achieves wider adoption and higher-quality implementation
Leverage Proposition: Scale-up and sustainability are more likely when organizational governance, values, resources, and structure are leveraged in design
The IRPP process model represents a collaborative, multi-level systems approach to developing, testing, and sustaining evidence-based principles within real-world settings [33]. This model adapts Rogers' Diffusion of Innovations framework, operationalizing co-production through five iterative stages:
Central to this process is the continual emphasis on collaboration among practice professionals, organizational decision-makers, and scientists, with the partnership serving as the decision-making unit [33].
Substantial evidence demonstrates the practical advantages of IRPPs over traditional pipeline models. A cluster randomized controlled trial comparing an IRPP-developed physical activity program (FitEx) with an evidence-based program developed through traditional methods (ALED) revealed significant differences in implementation outcomes [34].
Table 1: Comparative Outcomes of IRPP vs. Pipeline-Model Interventions
| Outcome Metric | IRPP-Developed Program (FitEx) | Pipeline-Model Program (ALED) | Statistical Significance |
|---|---|---|---|
| Health Educator Adoption | 14 of 18 HEs | 2 of 18 HEs | χ² = 21.8; p < 0.05 |
| Participant Reach | 1,097 total participants | 27 total participants | Substantially higher |
| Delivery Time | Less time required | More time required | p < 0.05 |
| Intent to Continue | Greater intention for continued delivery | Lower intention for continued delivery | p < 0.05 |
| Participant PA Improvement | 9.12 ±29.09 min/day increase | Similar increase | Not significant (p > 0.05) |
This evidence demonstrates that IRPP-developed programs can significantly improve adoption, implementation, and maintenance while achieving broader reach—without compromising effectiveness [34].
The RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework provides a practical structure for planning and evaluating IRPP initiatives [33] [34]. Within IRPPs, RE-AIM dimensions are pragmatically identified during evaluation and decision-making phases, with target metrics established for each dimension [33]:
This framework enables both researchers and practitioners to easily communicate, measure, and address implementation outcomes in practice settings [33] [34].
Phase 1: Foundation Building
Phase 2: Structural Formalization
The development of pragmatic measures for assessing co-creation quality involves a structured validation process [36]:
Table 2: Co-Creation Measurement Validation Protocol
| Phase | Sample Size | Methodology | Outcomes |
|---|---|---|---|
| Delphi Process | 16-20 expert panel members | Group discussions and rating exercises | Construct delineation, content validity assessment |
| Cognitive Interviews | 40 participants | Iterative coding process | Item comprehension and interpretation analysis |
| Psychometric Validation | 300 participants | Confirmatory and exploratory factor analysis | Survey reliability, validity, and pragmatic characteristics |
This protocol produces a two-component measure consisting of: (1) an iterative group assessment to prioritize cocreation principles and identify specific activities, and (2) a survey assessing individual partner experience [36].
Hybrid Effectiveness-Implementation Design [34]
Data Collection Methods
Table 3: Essential Resources for IRPP Implementation
| Tool Category | Specific Instrument | Function | Application Context |
|---|---|---|---|
| Evaluation Framework | RE-AIM | Planning and evaluating implementation outcomes | Across all partnership phases [33] [34] |
| Partnership Structure | Vertical and Horizontal Systems Approach | Engaging multiple organizational levels and sectors | Partnership establishment [33] |
| Implementation Strategy | Multiphase Optimization Strategy (MOST) | Optimizing implementation strategy packages | Preparation, optimization, evaluation phases [37] |
| Co-creation Measure | Pragmatic Co-creation Measure | Assessing quality of collaborative process | Partnership quality assurance [36] |
| Trial Design | Hybrid Type 3 Trial | Simultaneously testing effectiveness and implementation | Integration trials [34] |
The Multiphase Optimization Strategy (MOST) provides a principled framework for developing, optimizing, and evaluating multicomponent implementation strategies within IRPPs [37]. This approach includes:
Preparation Phase
Optimization Phase
Evaluation Phase
IRPPs have demonstrated significant value in patient-centric drug development, particularly in creating clinical outcome assessment strategies that accurately reflect patient experiences [38] [35]. A notable application involved co-creating clinical outcome assessments for early-stage Parkinson's disease through partnership between a pharmaceutical company (UCB), patient organizations (Parkinson's UK and Parkinson's Foundation), and clinical experts [35].
Key outcomes included:
This collaboration required considerable resource allocation for planning, communication, and documentation but resulted in outcome assessments that were more holistic and relevant to the patient experience [35].
In public health contexts, IRPPs have successfully addressed physical activity promotion through partnerships between university researchers and cooperative extension systems [34]. These partnerships balanced scientific evidence on physical activity promotion with the practical needs and system capabilities of community delivery organizations, resulting in programs with higher adoption, reach, and sustainability compared to traditional evidence-based programs [34].
The field of implementation science is evolving toward greater integration of research and practice, with several emerging trends shaping IRPP development [39]:
Emphasis on Healthcare Access: IRPPs increasingly focus on communities lacking reliable access to health resources, tailoring interventions to address specific access barriers
Digital Integration: Expanded use of telehealth and digital tools extends the reach of IRPP-developed interventions to remote and underserved populations
Cross-Sector Collaboration: Growing recognition that complex health challenges require collaborative approaches across public, private, and community sectors
Pragmatic Trial Methodologies: Movement toward embedded pragmatic clinical trials that assess interventions in real-world settings with broad patient populations [40] [41]
Implementation Strategy Optimization: Application of optimization frameworks like MOST to develop more efficient and effective implementation strategy packages [37]
These trends highlight the continuing evolution of IRPPs toward more responsive, efficient, and impactful research-practice integration that accelerates the translation of evidence into practice while maintaining scientific rigor.
Contextual inquiry, the process of using in-depth mixed methods to understand implementation contexts, is a critical first step in implementation science for identifying barriers and facilitators to evidence-based practice (EBP) adoption [42]. However, traditional approaches often require one to two years to complete, focus on single settings or EBPs, and frequently duplicate prior efforts, contributing to significant translational lag in bringing interventions to scale [42]. Within the framework of developing pragmatic measures for implementation science research, this application note establishes streamlined protocols for rapid contextual inquiry that balance scientific rigor with speed, enabling more efficient pre-implementation assessment while preserving the relationship-building activities fundamental to implementation success [42] [23].
The pragmatic approach advocated here addresses several critical limitations of traditional contextual inquiry methods. First, it emphasizes collaborative research designs that identify determinants across different settings and EBPs, using rapid approaches when possible [42]. Second, it promotes enhanced synthesis of existing research on implementation determinants to minimize duplication of effort [42]. Third, it requires clear rationale for why additional contextual inquiry is needed before undertaking new data collection [42]. This methodology is particularly valuable for drug development professionals and researchers working under resource constraints who need to quickly identify implementation barriers while maintaining methodological rigor.
Rapid Ethnography and Deductive Analysis: This approach involves gathering qualitative data on a brief, clearly delineated timeline while maintaining methodological integrity [42]. The protocol begins with developing a structured interview guide based on established implementation frameworks, such as the Consolidated Framework for Implementation Research (CFIR) or CFIR integrated with Health Equity (CFIR/HE) [43]. Participants should include key implementation team members, patients, and other relevant stakeholders [43]. Data collection should be focused and time-limited, with interviews typically lasting 45-60 minutes. Analysis employs rapid deductive qualitative methods using pre-established codebooks derived from implementation frameworks, allowing for efficient categorization of barriers and facilitators without the time-intensive process of inductive code development [42] [23].
Structured Template Summarization: For even greater efficiency, research teams can utilize rapid analysis of qualitative data by summarizing interview transcripts using structured templates [42]. This protocol involves creating a standardized summary template that captures major themes aligned with implementation framework domains. Research team members independently review transcripts and complete templates, followed by collaborative synthesis sessions to identify convergent and divergent themes. Studies have demonstrated consistency between this method and in-depth analysis, with one investigation finding no significant information gaps between approaches [42].
The brainwriting premortem is a proactive approach to identifying potential implementation barriers before they occur [23]. This protocol begins with assembling key stakeholders from the implementation setting. Participants independently document reasons why implementation efforts might fail, focusing specifically on the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework dimensions [23]. Following independent brainstorming, facilitators consolidate responses and lead structured discussions to prioritize barriers based on probability and impact. This method efficiently leverages collective expertise while avoiding groupthink that can occur in traditional brainstorming sessions.
Card Sort Prioritization: When contextual inquiry reveals multiple barriers, research-practice partnerships must systematically determine which to address first [23]. This protocol involves writing identified barriers on individual cards and asking stakeholders to sort them into priority categories (e.g., high, medium, low) based on criteria such as changeability and impact [23]. The process can be conducted in person or using digital collaboration tools, with results tallied to identify consensus priorities.
Modified Conjoint Analysis: This more structured approach involves rating barriers through surveys or by physically placing sticky notes with each barrier on a 2×2 grid poster board with axes representing importance and changeability [23]. Stakeholders individually rate or place barriers, followed by facilitated discussion to reach consensus on which barriers represent the highest priorities for addressing through implementation strategies.
Table 1: Comparison of Rapid Contextual Inquiry Methods
| Method | Time Requirement | Data Output | Best Use Cases |
|---|---|---|---|
| Rapid Ethnography with Deductive Analysis | 2-4 weeks | Categorized barriers and facilitators mapped to implementation frameworks | Novel settings or EBPs where some prior research exists |
| Structured Template Summarization | 1-2 weeks | High-level thematic summary of key barriers and facilitators | Settings with time constraints; verification of known determinants |
| Brainwriting Premortem | 1-2 sessions | Proactive identification of potential failure points | Early implementation planning; complementing empirical data |
| Card Sort Prioritization | Single session | Rank-ordered list of implementation barriers | Multi-stakeholder teams; when numerous barriers are identified |
While contextual inquiry often emphasizes qualitative methods, quantitative analysis provides critical support for understanding implementation contexts and measuring differences between groups [44]. The protocol for quantitative analysis begins with descriptive statistics to characterize the sample, including means, medians, modes, standard deviations, and skewness [44]. When comparing quantitative variables between groups, researchers should generate appropriate visualizations such as boxplots for summarizing distributions or dot charts for smaller datasets [45]. For comparative analyses, calculate differences between group means or medians, ensuring that measures of variance (standard deviations, interquartile ranges) and sample sizes are reported for each group [45].
Table 2: Essential Quantitative Measures for Contextual Inquiry
| Statistical Measure | Calculation Method | Interpretation in Contextual Inquiry |
|---|---|---|
| Descriptive Statistics | ||
| Mean | Sum of values divided by number of observations | Average level of a construct across participants |
| Standard Deviation | Measure of dispersion around the mean | Variability in responses; higher values indicate greater diversity |
| Between-Group Comparisons | ||
| Difference Between Means | Mean of Group A - Mean of Group B | Magnitude of difference between stakeholder groups |
| Interquartile Range (IQR) | Q3 - Q1 | Spread of middle 50% of responses; useful for skewed data |
The final analytical protocol involves mapping identified barriers and facilitators to implementation frameworks to guide strategy selection. Using CFIR/HE ensures systematic consideration of multilevel determinants while explicitly addressing health equity considerations [43]. The process involves creating a determinant matrix that links identified factors to specific CFIR domains (intervention characteristics, outer setting, inner setting, individual characteristics, process) while noting equity implications using the health equity framework [43]. This structured approach facilitates more targeted implementation strategy selection.
Table 3: Essential Research Reagents for Contextual Inquiry
| Reagent/Resource | Function | Application Notes |
|---|---|---|
| Structured Interview Guides | Standardized data collection aligned with implementation frameworks | Ensure inclusion of CFIR/HE domains; customize for specific setting |
| Rapid Analysis Templates | Efficient summarization of qualitative data | Pre-populate with implementation framework constructs |
| Determinant Prioritization Matrix | Visual tool for ranking barriers by importance and changeability | Use 2×2 grid; include criteria for ranking |
| Implementation Framework Codebooks | Deductive coding of qualitative data | CFIR/HE codebooks available through implementation science repositories |
Integrated Research-Practice Partnership Workflow
Rapid Contextual Inquiry Process
The Multiphase Optimization Strategy (MOST) is a comprehensive framework for developing and optimizing multicomponent interventions. In implementation science, MOST offers a principled approach to empirically identifying the combination of implementation strategies that produces the best expected outcomes given constraints imposed by the need for affordability, scalability, and efficiency [46] [37]. This represents a paradigm shift from the traditional approach of packaging multiple implementation strategies together and evaluating them as a whole in a two-arm randomized controlled trial (RCT). Instead, MOST enables researchers to systematically assess which strategies contribute meaningfully to implementation outcomes, and how they interact [37].
The core principle of MOST is to achieve intervention EASE, strategically balancing:
For implementation scientists, this means treating a package of implementation strategies as a type of intervention that can be optimized, moving beyond the limitations of evaluating multifaceted strategies without understanding each component's individual contribution and potential interactions [37].
MOST comprises three sequential phases: Preparation, Optimization, and Evaluation [46] [37]. The framework can be applied to various implementation science scenarios, four of which are summarized in the table below.
Table 1: Phases of the MOST Framework
| Phase | Primary Objective | Key Activities |
|---|---|---|
| Preparation | Lay foundation for optimization | Develop conceptual model; identify candidate implementation strategies; conduct pilot work; specify optimization objective [37]. |
| Optimization | Empirical testing of components | Conduct optimization RCT (e.g., factorial design); assess performance of strategies independently and in combination [46] [37]. |
| Evaluation | Confirm effectiveness of optimized package | Evaluate optimized implementation strategy package in a standard RCT [37]. |
Table 2: Application Scenarios for MOST in Implementation Science
| Scenario | Description | Hypothetical Example |
|---|---|---|
| Developing new multifaceted implementation strategies | Building a new package of strategies from discrete components. | Creating a comprehensive plan to implement a school-based physical activity program [46]. |
| Evaluating program-implementation strategy interactions | Examining how intervention components interact with implementation strategies. | Studying how a treatment guide's effectiveness is influenced by different training modalities [46]. |
| Deconstructing established multifaceted strategies | Testing individual components of a previously bundled strategy. | Isolating effects of audit, feedback, and leadership buy-in from a previously combined "technical assistance" strategy [46]. |
| Local adaptation of strategies | Modifying discrete or multifaceted strategies for a specific context. | Adapting a clinic-level implementation strategy for a new healthcare system with different resource constraints [46]. |
The optimization phase typically employs an optimization RCT, with the factorial design being a common and efficient choice [37]. This design allows for the simultaneous testing of multiple implementation strategy components and their interactions. The following workflow diagram illustrates the key decision points in this phase.
Hypothetical Example: Optimizing Implementation of a Smoking Cessation EBI This protocol outlines the steps for optimizing a package of implementation strategies to improve clinic-level adoption of an evidence-based smoking cessation intervention [37].
Background and Preparation Phase Outputs:
Table 3: Optimization RCT (2^4 Factorial Design) Specifications
| Design Element | Specification |
|---|---|
| Experimental Design | Fully randomized 2^4 factorial design |
| Number of Conditions | 16 (all possible combinations of the 4 strategies, each present or absent) |
| Randomization Unit | Clinic (cluster randomization) |
| Primary Outcome | Clinic-level adoption rate (proportion of eligible patients receiving EBI) |
| Secondary Outcomes | Implementation fidelity, cost, provider satisfaction |
| Key Analyses | Main effects of each strategy; two-way and higher-order interactions |
Procedure:
Quantitative data analysis in MOST utilizes specific methods to derive meaningful insights from optimization RCTs [47]. The primary analysis focuses on main effects and interaction effects using factorial ANOVA.
Table 4: Quantitative Data Analysis Methods for MOST
| Analysis Type | Purpose | Application in MOST |
|---|---|---|
| Descriptive Analysis | Understand what happened in the data [47]. | Calculate average adoption rates for each experimental condition. |
| Diagnostic Analysis | Understand why it happened by examining relationships between variables [47]. | Analyze relationships between strategy combinations and outcomes. |
| Factorial ANOVA | Test main effects and interaction effects of multiple factors. | Determine significance of each implementation strategy and their interactions. |
| Cost-Effectiveness Analysis | Evaluate economic efficiency of different components. | Compare cost per additional adoption for each strategy component. |
The following diagram illustrates the logical relationship between experimental results, decision-making, and the final optimized package.
Table 5: Hypothetical Optimization Results and Decision-Making
| Implementation Strategy | Main Effect on Adoption (p-value) | Incremental Cost | Cost-Effectiveness Ratio | Decision |
|---|---|---|---|---|
| Training (T) | +12.4% (p<0.01) | $15,000 | $1,210 per additional adoption | Include |
| Treatment Guide (G) | +8.2% (p<0.05) | $2,500 | $305 per additional adoption | Include |
| Workflow Redesign (W) | +3.1% (p=0.18) | $8,000 | $2,580 per additional adoption | Exclude |
| Supervision (S) | +5.6% (p=0.07) | $12,000 | $2,143 per additional adoption | Exclude |
| Interaction T × G | +6.3% (p<0.05) | - | - | Reinforces inclusion of both |
Table 6: Essential Methodological Components for MOST Studies
| Research Component | Function in MOST | Implementation Examples |
|---|---|---|
| Conceptual Model | Serves as the theoretical blueprint depicting how implementation strategies will produce desired outcomes [37]. | CFIR (Consolidated Framework for Implementation Research); Theoretical Domains Framework. |
| Optimization Objective | Specifies how effectiveness will be balanced with implementation constraints [37]. | "Maximize adoption rate with total cost ≤ $20,000 per clinic"; "Achieve 80% adoption with minimal provider time burden." |
| Factorial Experimental Design | Enables efficient assessment of multiple strategy components simultaneously [46] [37]. | 2^k factorial design; fractional factorial design for screening; sequential multiple assignment randomized trial (SMART). |
| Implementation Outcome Measures | Quantifies the success of implementation efforts. | Adoption rate; fidelity; cost; sustainability; provider acceptability [37]. |
| Resource Tracking System | Captures data on affordability and scalability constraints. | Time-motion studies; cost accounting systems; provider workload assessment. |
Achieving public health impact with evidence-based interventions (EBIs) requires careful balancing of multiple competing priorities. The EASE framework (balancing Effectiveness, Affordability, Scalability, and Efficiency) provides a principled approach to this challenge within implementation science [48]. The EASE framework is operationalized through the Multiphase Optimization Strategy (MOST), a comprehensive framework for developing, optimizing, and evaluating multicomponent interventions and implementation strategies [37] [49].
MOST represents a paradigm shift from the classical "treatment package" approach, where multiple components are bundled and evaluated as a single unit through randomized controlled trials (RCTs). Instead, MOST employs a more strategic process that treats individual implementation strategies as candidate components that may or may not ultimately be included in the final implementation package [37]. This approach allows researchers to answer critical questions about which components drive effectiveness, whether components interact with each other, and how to achieve the best outcomes within real-world constraints [48].
The framework consists of three sequential phases: Preparation (laying the conceptual and methodological foundation), Optimization (empirically testing candidate components), and Evaluation (rigorously testing the optimized package) [37]. By strategically balancing EASE criteria throughout these phases, implementation scientists can develop implementation strategies that not only work but are also practical, sustainable, and ready for widespread dissemination [48].
Within the EASE framework, each dimension represents a critical consideration for implementation success:
The MOST framework provides a structured methodology for achieving EASE in implementation design through three distinct phases [37]:
Factorial designs, particularly the 2^k factorial experiment where each of the k factors (implementation strategies) is evaluated at two levels (present/absent), serve as a cornerstone experimental approach in the optimization phase of MOST [48] [37]. These designs enable efficient assessment of both the main effects of each implementation strategy and their interactions [48]. This methodology allows researchers to answer not only whether each discrete strategy has a positive, negative, or null effect on implementation outcomes, but also how strategies work in the presence or absence of one another [48] [37].
Table 1: Key Advantages of Factorial Designs for Implementation Optimization
| Advantage | Methodological Explanation | Impact on EASE |
|---|---|---|
| Simultaneous Evaluation | All candidate components tested in a single, efficient experiment | Enhances Efficiency and Affordability of research process |
| Interaction Detection | Ability to identify synergistic or antagonistic effects between components | Improves Effectiveness through strategic component combinations |
| Resource Management | All research participants contribute to estimating all effects | Maximizes Efficiency of research resources and participant recruitment |
| Informed Decision-Making | Empirical data on performance and resource requirements for each component | Supports Scalability by identifying essential, high-impact components |
The integration of MOST and EASE principles addresses several critical scenarios in implementation science [48]:
The following diagram illustrates the sequential workflow for applying the EASE framework through the MOST process, from conceptualization to sustained implementation:
A robust conceptual model is essential during the preparation phase to guide optimization. The following diagram illustrates the key constructs and their hypothesized relationships when optimizing implementation strategies for a school-based physical activity intervention, as described in the search results [48]:
Objective: To empirically test discrete implementation strategies and their interactions to identify the most effective, affordable, scalable, and efficient combination.
Table 2: Factorial Optimization Trial Protocol Components
| Protocol Element | Specifications | EASE Considerations |
|---|---|---|
| Design | Full or fractional 2^k factorial design where k = number of candidate implementation strategies [48] |
Maximizes information yield per participant (Efficiency) |
| Randomization | Individual or cluster randomization depending on implementation context and level of analysis [37] | Ensures internal validity of effect estimates (Effectiveness) |
| Implementation Strategies | Selected based on conceptual model, prior evidence, and preliminary work; each operationalized with clear specification [48] | Enables precise replication and accurate cost estimation (Scalability, Affordability) |
| Primary Outcomes | Implementation outcomes (e.g., acceptability, fidelity, adoption) and/or clinical outcomes as appropriate [48] | Directly addresses implementation success (Effectiveness) |
| Sample Size | Powered to detect main effects and important interactions [37] | Balances statistical power with resource constraints (Efficiency, Affordability) |
| Data Analysis | Factorial ANOVA with effect coding to examine main effects and interactions [48] [37] | Provides unbiased estimates of individual and combined effects (Effectiveness) |
| Resource Tracking | Systematic documentation of time, materials, and personnel requirements for each strategy [37] | Enables Affordability and Scalability assessment |
Objective: To systematically identify and refine candidate implementation strategies for testing in the optimization phase.
Table 3: Essential Methodological Tools for Implementation Optimization Research
| Research Tool | Function | Application Context |
|---|---|---|
| Conceptual Model Template | Maps hypothesized relationships between strategies, mediators, and outcomes [48] | Preparation phase; guides component selection and measurement |
| Strategy Specification Checklist | Ensures complete description of implementation strategies per reporting guidelines [48] | Protocol development; enhances reproducibility |
| Factorial Design Generator | Creates randomization schemes for 2^k factorial experiments |
Optimization phase; ensures proper experimental design |
| Cost Tracking Instrument | Systematically captures resource utilization for each strategy component [37] | Economic evaluation; informs affordability assessment |
| Implementation Outcome Measures | Validated instruments for acceptability, feasibility, appropriateness, etc. [48] | Outcome assessment; measures implementation success |
| Mediator Measures | Assesses hypothesized mechanisms of action (e.g., knowledge, self-efficacy) [48] | Process evaluation; tests conceptual model |
| Optimization Decision Framework | Structured approach for selecting final package based on EASE criteria [37] | Interpretation phase; guides decision-making |
Analysis of factorial optimization trials focuses on estimating both main effects and interaction effects. The following table illustrates hypothetical data from a school-based physical activity implementation study with three candidate strategies [48]:
Table 4: Hypothetical Main and Interaction Effects on Implementation Outcome (Acceptability)
| Implementation Strategy | Main Effect (β) | 95% CI | p-value | Cost per Unit | Staff Time (hours) |
|---|---|---|---|---|---|
| Educational Outreach | 0.45 | (0.32, 0.58) | <0.001 | $150 | 2.5 |
| Technical Assistance | 0.28 | (0.15, 0.41) | 0.002 | $275 | 5.0 |
| Expert Shadowing | 0.12 | (-0.01, 0.25) | 0.072 | $450 | 8.0 |
| EdOut × TechAssist | 0.18 | (0.05, 0.31) | 0.021 | - | - |
| EdOut × Shadowing | -0.08 | (-0.21, 0.05) | 0.245 | - | - |
| TechAssist × Shadowing | 0.05 | (-0.08, 0.18) | 0.482 | - | - |
Based on the hypothetical data above, researchers would apply their pre-specified optimization objective to select the final implementation package. The following decision matrix illustrates how EASE considerations can be balanced:
Table 5: Implementation Package Decision Matrix Based on EASE Criteria
| Strategy Combination | Expected Effectiveness | Total Cost | Staff Time | Scalability Potential | EASE Balance |
|---|---|---|---|---|---|
| Educational Outreach Only | Medium | $150 | 2.5 hours | High | Favors Affordability/Scalability |
| EdOut + TechAssist | High (with synergy) | $425 | 7.5 hours | Medium | Balanced EASE Profile |
| All Three Strategies | High (diminishing returns) | $875 | 15.5 hours | Low | Favors Effectiveness |
The final selection of implementation components follows a systematic decision process based on empirical data and pre-specified constraints, as illustrated below:
A major gap in implementation research is the lack of guidance for designing studies to assess the impact of adaptations to interventions and implementation strategies [51]. While many researchers regard experimental designs as the gold standard, the possible study designs for assessing the impact of adaptation on implementation, service, and person-level outcomes is broad in scope, including descriptive and correlational research and variations of randomized controlled trials [51]. This article provides a set of key methodological recommendations for assessing the impact of adaptations to interventions and implementation strategies on implementation outcomes, framed within the broader context of developing pragmatic measures for implementation science research.
We recommend that study teams first define the construct of adaptations and identify the type and timing of adaptations [51]. Adaptation has been defined as "a process of thoughtful and deliberate alteration to the design or delivery of an intervention, with the goal of improving its fit or effectiveness in a given context" [51]. When time and resources are limited, we recommend assessing seven key aspects of adaptations [51]:
Table 1: Framework for Documenting Adaptation Characteristics
| Characteristic | Documentation Elements | Data Collection Methods |
|---|---|---|
| What | Specific components, activities, or protocols modified | Implementation logs, stakeholder interviews |
| Focus | Intervention core functions vs implementation strategies | FRAME-IS coding, team meeting documentation |
| Timing | Before, during, or after implementation; sequence of multiple adaptations | Timeline mapping, prospective tracking |
| Reason | Improve fit, address barriers, enhance equity, increase reach | Structured interviews, adaptation tracking forms |
| Context | Setting characteristics, external factors influencing adaptation | Context assessment, environmental scans |
We recommend that study teams identify and specify the expected proximal and distal outcomes of adaptations [51]. This involves conceptualizing, assessing, and reporting both immediate and longer-term outcomes of adaptations to interventions and/or strategies. Key considerations include [51]:
Table 2: Adaptation Outcomes Framework
| Outcome Level | Proximal Outcomes | Distal Outcomes | Measurement Approaches |
|---|---|---|---|
| Implementation | Feasibility, acceptability, appropriateness | Fidelity, penetration, sustainability | Provider surveys, fidelity checklists, administrative data |
| Service | Reach, service quality, equity of delivery | Service efficiency, patient experience | Patient surveys, clinical records, quality indicators |
| Client/Person | Engagement, satisfaction, intermediate outcomes | Health status, quality of life, long-term outcomes | Clinical assessments, patient-reported outcomes |
We recommend that study teams consider all possible study design options and choose the design that is best suited to answer the research question(s) while balancing logistical constraints and challenges [51]. The selection of study designs for adaptation research should consider [51]:
We recommend that study teams consider the type of adaptation and outcome data available, the goals of the adaptation study, and the complexity of the study design when selecting analytic approaches [51]. Analytical considerations include:
Purpose: To systematically document adaptations as they occur during implementation.
Materials:
Procedure:
Deliverables:
Purpose: To identify and characterize adaptations after implementation has occurred.
Materials:
Procedure:
Deliverables:
Table 3: Essential Methodological Tools for Adaptation Research
| Tool Category | Specific Tool/Resource | Function/Purpose | Application Context |
|---|---|---|---|
| Documentation Frameworks | FRAME (Framework for Reporting Adaptations and Modifications) [51] | Systematic documentation of adaptations to interventions | Characterizing what, why, and how adaptations occur |
| Documentation Frameworks | FRAME-IS (Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies) [51] | Documenting modifications to implementation strategies | Tracking changes to implementation approaches |
| Conceptual Models | MADI (Model for Adaptation Design and Impact) [51] | Creating explanatory models for adaptations' impact on outcomes | Hypothesis development about adaptation-outcome relationships |
| Conceptual Models | PRISM (Practical, Robust Implementation and Sustainability Model) [51] | Tailoring iterative adaptations based on implementation priorities | Guiding adaptation decisions during implementation |
| Data Collection Tools | Prospective adaptation tracking forms | Real-time documentation of adaptations as they occur | Ongoing implementation quality improvement |
| Data Collection Tools | Retrospective interview guides | Reconstruction of adaptation history after implementation | Post-implementation evaluation studies |
| Analytical Approaches | Multi-level modeling | Accounting for nested data structures in adaptation studies | Studies with adaptations at multiple levels |
| Analytical Approaches | Qualitative comparative analysis | Identifying configurations of adaptations associated with outcomes | Complex adaptation patterns across multiple sites |
The "Core Functions and Forms" model represents a paradigm shift in implementation science, reframing how fidelity and adaptation are conceptualized and operationalized [52]. This model provides a critical framework for making deliberate adaptation decisions to improve the fit of Evidence-Based Practices (EBPs) in new contexts without compromising their effectiveness.
This distinction enables a crucial shift from prioritizing strict form fidelity (reproducing an EBP's protocol based on prior operationalization) to emphasizing function fidelity (maintaining fidelity to the underlying purpose of intervention components) when implementing in novel settings [52].
The Functions-Forms paradigm can be systematically integrated throughout all phases of the Exploration, Preparation, Implementation, Sustainment (EPIS) framework to guide adaptation decisions [52]:
Table 1: Functions-Forms Integration Throughout EPIS Framework
| EPIS Phase | Key Functions-Forms Applications | Primary Objectives |
|---|---|---|
| Exploration | Focusing on both function and form to guide EBP selection | Identify EBPs with core functions aligning with local context goals while having forms adaptable to the setting |
| Preparation | Using function-form matrices to guide adaptation decisions and measurement protocols | Develop localized EBP adaptations while planning monitoring of both form and function fidelity |
| Implementation | Informing data collection and feedback strategies | Identify how pre-planned and ad-hoc adaptations impact implementation, service, and clinical outcomes |
| Sustainment | Analyzing process and outcomes data to evaluate fidelity levels | Generate hypotheses about what is truly "core" versus "adaptable" in the new context for future iterations |
Recent methodological advancements provide structured approaches for investigating adaptation impact [51]:
When tracking adaptations, seven key aspects should be documented: what was adapted, focus of adaptation, purpose, timing and sequence, whether bundled with other adaptations, scope and frequency, and whether planned or responsive [51].
Strong measurement is critical for monitoring and evaluating adaptation efforts in implementation practice [53]. The selection of high-quality implementation measures connects individual adaptation initiatives to broader implementation science through a structured Measurement Roadmap:
The Inventory of Factors Affecting Successful Implementation and Sustainment (IFASIS) provides a validated, pragmatic quantitative instrument for assessing organizational context [54]. This 27-item, team-based measure operationalizes context through two rating scales capturing current state and importance of each item to an organization. It demonstrates strong reliability, internal consistency, and predictive validity, with significant associations between higher IFASIS scores and improved implementation outcomes [54].
Purpose: To systematically evaluate and prioritize potential adaptations while preserving core functions.
Materials:
Procedure:
Intervention Deconstruction
Context Assessment
Adaptation Identification
Adaptation Prioritization
Monitoring Framework
The following diagram illustrates the core decision process for evaluating adaptations while maintaining functional fidelity:
Table 2: Essential Research Reagents for Adaptation Science
| Tool/Instrument | Function | Application Context |
|---|---|---|
| FRAME/FRAME-IS | Systematic documentation of modifications to interventions and implementation strategies | Tracking adaptations during implementation; categorizing adaptation characteristics [51] |
| IFASIS | Quantitative assessment of organizational context factors affecting implementation | Measuring contextual determinants pre- and post-adaptation; predicting implementation outcomes [54] |
| Functions-Forms Matrix | Mapping relationship between intervention components and core functions | Planning and evaluating adaptations; maintaining function fidelity during adaptation [52] |
| ADAPT Guidance | Process model for adapting and transferring EBIs to new contexts | Structured approach to adaptation process from planning to sustainment [51] |
| Measurement Roadmap | Structured process for selecting implementation measures | Identifying appropriate measures for monitoring adaptation impact [53] |
Effective data visualization is essential for analyzing adaptation impact across multiple dimensions:
Table 3: Visualization Approaches for Adaptation Data Analysis
| Data Type | Recommended Visualization | Analytical Purpose |
|---|---|---|
| Comparison of outcomes across adapted vs. non-adapted components | Boxplots [45] | Display distribution differences; identify outliers and central tendencies |
| Tracking implementation outcomes over time | Line charts [55] | Visualize trends, increases, declines, or seasonality in outcome data |
| Relationship between number of adaptations and implementation outcomes | Scatter plots [55] | Explore correlations and identify patterns or clusters |
| Part-to-whole relationships of adaptation types | Treemap charts [55] | Show hierarchical data and proportions of different adaptation categories |
| Multivariate analysis of context, adaptations, and outcomes | Heatmap charts [55] | Identify complex patterns across multiple variables simultaneously |
Purpose: To quantitatively evaluate the impact of adaptations on implementation and effectiveness outcomes.
Experimental Design:
Data Collection:
Analysis Plan:
The Functions-Forms paradigm, supported by structured protocols and pragmatic measures, enables implementation researchers and practitioners to make systematic, evidence-informed adaptation decisions that preserve the essential elements of evidence-based interventions while optimizing their fit for diverse contexts and populations.
In implementation science, dynamic barriers are contextual and methodological challenges that evolve throughout the research process, potentially compromising the validity, reliability, and relevance of study findings. These barriers systematically introduce error by preventing the unprejudiced consideration of research questions, ultimately threatening the successful adoption of evidence-based interventions in real-world settings [56]. Unlike static methodological issues, dynamic barriers manifest and transform across the planning, data collection, analysis, and publication phases of research, requiring equally dynamic and vigilant mitigation strategies [56]. For researchers and drug development professionals, understanding these barriers is paramount to developing pragmatic measures that maintain their scientific rigor and practical relevance throughout implementation processes.
The most insidious dynamic barriers include various forms of research bias that can distort evidence generation, particularly in longitudinal studies where measurement instruments must remain valid across temporal, contextual, and technological shifts. As implementation science seeks to bridge the gap between evidence and practice in healthcare, systematically addressing these barriers becomes essential for creating system-wide change and achieving adoption at scale [57]. This document provides application notes and protocols for identifying, monitoring, and mitigating these dynamic barriers throughout the implementation research lifecycle.
Bias in research represents "systematic error introduced into sampling or testing by selecting or encouraging one outcome or answer over others" [56]. Unlike random error, which decreases with increasing sample size, bias is independent of both sample size and statistical significance and can cause estimates of association to be either larger or smaller than the true association [56]. In extreme cases, bias can cause a perceived association directly opposite of the true association, as demonstrated in historical studies of hormone replacement therapy where initial observational studies showed decreased risk of heart disease, while more rigorous later studies found increased risk [56].
Table 1: Categorization of Major Research Biases and Mitigation Approaches
| Bias Type | Phase of Occurrence | Definition | Primary Mitigation Strategies |
|---|---|---|---|
| Selection Bias | Pre-trial | When criteria for recruiting patients into study cohorts are inherently different [56] | Use rigorous, predefined selection criteria; prospective designs where outcome is unknown at enrollment [56] |
| Channeling Bias | Pre-trial | Patient prognostic factors dictate study cohort assignment [56] | Randomization; clearly defined assignment protocols blind to prognostic factors [56] |
| Interviewer Bias | During trial | Systematic difference in how information is solicited, recorded, or interpreted [56] | Standardize interviewer interactions; blind interviewers to exposure status [56] |
| Recall Bias | During trial | Differential recall of information between groups based on outcomes or exposures [56] | Use objective data sources; corroborate with medical records; prospective designs [56] |
| Performance Bias | During trial | Unequal provision of care or exposure apart from the intervention under investigation [56] | Cluster stratification; standardization of procedures; blinding where possible [56] |
| Chronology Bias | During trial | Differences arising from use of historic controls affected by secular trends [56] | Use concurrent controls; limit use of historic controls to recent past [56] |
| Transfer Bias | During trial | Unequal follow-up or loss to participants across study groups [56] | Design comprehensive follow-up plan prior to study; intention-to-treat analysis [56] |
| Citation Bias | Post-trial | Selective citation of positive or statistically significant results [56] | Register trials in clinical trial registries; check for unpublished similar trials [56] |
Objective: To identify and mitigate potential biases during study design and patient recruitment phases, where errors can cause fatal flaws that cannot be compensated during data analysis.
Materials:
Procedure:
Validation: Conduct a preliminary assessment of measurement inter-rater reliability using intraclass correlation coefficients or kappa statistics, with targets >0.8 established before full study implementation.
Objective: To detect and address information biases that occur during data collection and patient follow-up.
Materials:
Procedure:
Validation: Regular interim monitoring of data collection consistency, loss-to-followup rates across groups, and blinding effectiveness.
Maintaining measure relevance in implementation science requires continuous assessment of contextual factors that evolve throughout the research process. The Normalization Process Theory (NPT) provides a theoretical foundation for understanding how new practices become embedded and sustained, offering mechanisms to monitor and maintain relevance [58]. The ISAC Match process further provides a pragmatic matching process for selecting and tailoring implementation strategies through integrated research-practice partnerships [59].
Table 2: Framework for Maintaining Measure Relevance Across Implementation Phases
| Implementation Phase | Relevance Threats | Monitoring Strategies | Adaptation Protocols |
|---|---|---|---|
| Planning | Measures lack fit with local context or implementation setting | Contextual inquiry; stakeholder engagement; review of practice-based evidence [59] | Tailor measures to local context while maintaining core constructs; use rapid deductive qualitative approaches [59] |
| Initial Implementation | Evolving understanding of intervention components and outcomes | Regular fidelity assessment; implementer feedback mechanisms [58] | Modify implementation strategies while protecting core intervention components |
| Sustainment | Organizational and system changes; intervention drift | Periodic measure re-validation; assessment of continued appropriateness [57] | Update measures to reflect new evidence or contexts while maintaining longitudinal comparability |
| Scale-Up | Variation across new settings and populations | Cross-contextual measure validation; assessment of measurement invariance [57] | Develop core measure adaption guidelines for new contexts |
The ISAC Match process provides a systematic four-step approach for selecting and tailoring implementation strategies to overcome dynamic barriers [59]:
Step 1: Contextual Inquiry
Step 2: Identify Existing Implementation Strategies
Step 3: Select Implementation Strategies
Step 4: Tailor Implementation Strategies
Objective: To quantitatively evaluate the stability and relevance of implementation measures over time and across contexts.
Materials:
Procedure:
Analytical Visualization: For quantitative comparison of measures across different groups or time periods, several visualization approaches are appropriate [45]:
Objective: To establish and maintain the psychometric properties of implementation measures throughout the research process.
Materials:
Procedure:
Research Bias Mitigation Workflow
Measure Relevance Maintenance Process
Table 3: Essential Methodological Tools for Implementation Research
| Tool Category | Specific Tool/Technique | Function | Application Context |
|---|---|---|---|
| Bias Assessment Tools | Cochrane Risk of Bias Tool | Systematically evaluates potential biases in study design | Clinical trials and intervention studies [56] |
| Implementation Frameworks | Normalization Process Theory (NPT) | Explains how practices become embedded in social contexts | Understanding implementation mechanisms [58] |
| Strategy Compilations | ISAC (Implementation Strategies Applied in Communities) | Provides community-appropriate implementation strategies | Community settings and non-clinical interventions [59] |
| Strategy Selection | ISAC Match Process | Four-step process for selecting/tailoring implementation strategies | Integrated research-practice partnerships [59] |
| Quantitative Analysis | Descriptive Statistics (Mean, Median, SD, IQR) | Summarizes and compares data across groups | Initial data exploration and group comparisons [45] [60] |
| Data Visualization | Boxplots, Line Charts, Bar Charts | Enables visual comparison of quantitative data across groups | Identifying patterns, trends, and outliers [62] [45] |
| Color Accessibility | Colorblind-Friendly Palettes (Okabe-Ito, ColorBrewer) | Ensures visualizations are accessible to colorblind users | All data visualization and presentation [63] [64] |
| Contextual Inquiry | Rapid Deductive Qualitative Approaches | Quickly identifies barriers and facilitators in new settings | When limited evidence exists on contextual factors [59] |
The development of reliable and valid measures is a cornerstone of advancing implementation science, as these measures allow practitioners to assess local implementation barriers, select appropriate strategies, monitor progress, and evaluate ultimate success [14]. However, for these measures to be truly useful in real-world practice settings, they must be not only psychometrically sound but also pragmatic – designed with stakeholder needs and practical constraints in mind [14]. Glasgow and Riley emphasized that practitioners are unlikely to utilize measures, even psychometrically strong ones, if they are not also pragmatic, highlighting considerations such as training requirements, time burden for administration and scoring, and overall feasibility in practice settings [14].
This document provides application notes and protocols for designing validation studies that span the methodological spectrum, from descriptive research to randomized controlled trials (RCTs), all framed within the context of developing and validating pragmatic measures for implementation science. The goal is to provide researchers, scientists, and drug development professionals with structured methodologies to generate rigorous, applicable evidence for their measurement tools.
The Psychometric and Pragmatic Evidence Rating Scale (PAPERS) was developed through stakeholder-driven research to establish criteria for assessing whether implementation measures are pragmatic [14]. This framework emerged from multiple studies that identified, refined, and prioritized the key characteristics of pragmatic measures, resulting in four primary domains and associated criteria outlined in the table below.
Table 1: The PAPERS Framework: Domains and Criteria for Pragmatic Measures
| Domain | Description | Specific Criteria |
|---|---|---|
| Useful | Measures produce actionable information for decision-making | Produces reliable and valid results; Informs clinical or organizational decision-making [14] |
| Compatible | Measures fit well with existing systems and workflows | Applicable; Fits organizational activities [14] |
| Acceptable | Measures are agreeable to stakeholders | Creates low social desirability bias; Relevant; Offers relative advantage; Acceptable to staff and clients; Low cost [14] |
| Easy | Measures are simple to implement and use | Uses accessible language; Efficient; Feasible; Easy to interpret; Creates low assessor burden; Items not wordy; Completed with ease; Brief [14] |
When designing validation studies for new implementation measures, researchers should incorporate the PAPERS criteria throughout the development process. The Useful domain emphasizes that measures must produce actionable information that informs decision-making in clinical or organizational contexts [14]. The Compatible domain requires that measures fit seamlessly within existing workflows and organizational activities [14]. The Acceptable domain addresses stakeholder perceptions, including low social desirability bias, relevance, and cost considerations [14]. Finally, the Easy domain focuses on practical implementation factors such as language accessibility, efficiency, and low assessor burden [14].
Selecting an appropriate study design is crucial in implementation science because it directly influences the validity, reliability, and applicability of research findings [65]. A well-chosen design ensures that research effectively addresses the complexities of implementing evidence-based practices in real-world settings while balancing rigor with feasibility [65].
The following table summarizes the primary study designs used in validation and implementation research, along with their key characteristics and applications.
Table 2: Study Designs for Validation and Implementation Research
| Study Design | Key Characteristics | Applications in Implementation Science | Considerations for Measure Validation |
|---|---|---|---|
| Randomized Controlled Trials (RCTs) | Random assignment to treatment or control groups; Reduces bias [65] | Tests effectiveness of implementation strategies under controlled conditions [65] | Provides high-quality evidence for measure validity but may lack real-world generalizability |
| Cluster Randomized Trials (cRCTs) | Groups (clusters) rather than individuals are randomized [65] | Evaluates group-level interventions in hospitals, schools, or communities [65] | Suitable for measures assessing organizational constructs or implementation climate |
| Stepped-Wedge Designs | All clusters receive intervention; timing is randomized and staggered [65] | Useful when intervention is considered beneficial; allows within- and between-cluster comparisons [65] | Enables longitudinal assessment of measure performance across different implementation phases |
| Pragmatic Trials | Evaluates interventions in real-world, routine practice settings [65] | Assesses how interventions perform in everyday practice with diverse populations [65] | Ideal for testing pragmatic qualities of measures in actual use contexts |
| Hybrid Designs | Simultaneously evaluates intervention effectiveness and implementation strategies [65] | Type 1: Focuses on effectiveness while gathering implementation dataType 2: Equal emphasis on bothType 3: Focuses on implementation while collecting effectiveness data [65] | Allows concurrent validation of measures while studying implementation processes |
The Multiphase Optimization Strategy (MOST) is a comprehensive framework for developing, optimizing, and evaluating multicomponent implementation strategies, which can be readily adapted for measure validation studies [65]. MOST consists of three sequential phases:
Objective: To evaluate the pragmatic qualities of implementation measures using stakeholder feedback.
Background: The pragmatic characteristics of measures significantly influence their adoption and use in real-world practice settings [14]. This protocol provides a systematic approach for assessing these characteristics.
Table 3: Research Reagent Solutions for Stakeholder Assessment
| Research Reagent | Function | Application Notes |
|---|---|---|
| PAPERS Criteria Checklist | Standardized assessment of pragmatic measure properties | Use the 11 criteria across Useful, Compatible, Acceptable, and Easy domains [14] |
| Stakeholder Delphi Protocol | Structured communication for achieving consensus | Engage 12+ stakeholders representing diverse implementation contexts [14] |
| Concept Mapping Methodology | Visual representation of stakeholder conceptualizations | Participants group terms and phrases into conceptually distinct categories [14] |
| Pragmatic Rating Scale (6-point) | Quantifies stakeholder perceptions of pragmatic qualities | Demonstrates sufficient variability across pragmatic criteria [14] |
Methodology:
Outcome Measures: Stakeholder ratings of pragmatic criteria importance; Level of consensus on key pragmatic dimensions; Refined list of prioritized pragmatic criteria.
Objective: To simultaneously evaluate the psychometric properties of implementation measures and the effectiveness of implementation strategies.
Background: Hybrid designs are particularly valuable in implementation science because they allow researchers to understand both clinical outcomes and implementation processes concurrently [65].
Methodology:
Outcome Measures: Measure reliability and validity indices; Implementation outcomes (adoption, fidelity, sustainability); Stakeholder perceptions of measure pragmatism; Contextual factor documentation.
Objective: To evaluate the implementation of a new measure across multiple sites using a sequential rollout design.
Background: Stepped-wedge designs are particularly useful in implementation science because they ensure all participants eventually receive the potentially beneficial strategy while providing robust data on its impact over time [65].
Methodology:
Outcome Measures: Measure performance metrics across implementation phases; Implementation outcomes by cluster and over time; Contextual factors influencing implementation success; Stakeholder satisfaction with the measure.
Effective data presentation is crucial for communicating validation study findings to diverse audiences. The table below summarizes appropriate visualization approaches for different types of validation data.
Table 4: Data Visualization Approaches for Validation Studies
| Data Type | Recommended Visualizations | Application in Validation Studies | Considerations |
|---|---|---|---|
| Stakeholder Prioritization | Bar charts, Pie charts | Display relative importance of pragmatic criteria [66] | Use with limited categories; show clear patterns [66] |
| Longitudinal Performance | Line graphs, Area charts | Track measure performance across implementation phases [66] | Show trends and fluctuations over time [66] |
| Comparative Analysis | Bar charts, Tables | Compare measure performance across sites or stakeholder groups [66] [67] | Facilitate detailed comparisons between data points [67] |
| Distribution Data | Histograms, Box plots | Display distribution of scores or response patterns [66] | Show frequency within intervals; identify outliers [66] |
| Structured Information | Tables with clear headers | Present detailed psychometric properties or protocol details [67] | Organize information for quick reference and comparison [67] |
When presenting data in tables, apply these formatting guidelines to enhance readability:
Designing robust validation studies for implementation measures requires careful consideration of both scientific rigor and practical applicability. By employing the appropriate methodological approaches—from descriptive research to randomized controlled trials—and incorporating the PAPERS framework's pragmatic criteria, researchers can develop measures that are not only psychometrically sound but also feasible and useful in real-world practice settings. The protocols outlined in this document provide structured methodologies for generating the evidence needed to support the use of implementation measures across diverse healthcare contexts and stakeholder groups.
The high prevalence of Opioid Use Disorders (OUD) among jail populations, coupled with an exceptionally high risk of fatal overdose in the weeks following release, presents a public health crisis of considerable magnitude. [68] [69] For nearly two decades, research has confirmed that individuals in jail settings are highly susceptible to fatal overdose, with risk of death more than 12 times higher than for individuals with OUD in the general population within the first two weeks post-release. [68] This creates a critical implementation opportunity for Medications for Opioid Use Disorder (MOUD), which are considered the gold standard treatment. [68] Despite this need, a significant treatment gap persists, with 56% of jails not providing MOUD, creating a pressing need for better implementation approaches in jail and the hand-off to the community. [68] [69]
Jails offer a particularly strategic setting for MOUD implementation due to their local control, short-term stays, high turnover, and nearly 11 million admissions annually, resulting in more frequent individual contact than longer-term state prisons. [68] The implementation gap in administering MOUD encounters multiple barriers, including stigmatization of substance use disorders, funding limitations, institutional design constraints, variable leadership support, restrictive policies, and communication barriers regarding MOUD effectiveness. [68]
A national randomized controlled trial directly compared two implementation strategies: NIATx external coaching and the Extension for Community Healthcare Outcomes (ECHO) model. [68] [69] The study employed a 2×2 factorial design across 25 jails and 13 community-based partners, comparing high- and low-dose coaching with and without ECHO over a 12-month intervention period followed by a 12-month sustainability phase. [68]
Table 1: Primary Quantitative Outcomes from Comparative Trial
| Outcome Measure | NIATx Coaching | ECHO Model | Statistical Significance |
|---|---|---|---|
| Buprenorphine Use | Significant increase | No significant increase | p < 0.01 [68] |
| Combined MOUD Use | Significant increase (47.44% intervention phase; 7.30% sustainability) | No significant increase | p < 0.01 [68] [69] |
| Methadone Use | No consistent, significant gains | No consistent, significant gains | Not Significant [68] |
| Injectable Naltrexone | No consistent, significant gains | No consistent, significant gains | Not Significant [68] |
| Overall MOUD Use | Greater gains with high-dose coaching | No significant increase compared to coaching | p = 0.517 [68] |
The trial demonstrated that coaching emerged as a more effective implementation strategy than ECHO for increasing buprenorphine use in jail settings. [68] [69] While high-dose coaching showed greater gains for MOUDs overall compared to low-dose coaching, these differences were statistically insignificant (p = 0.124), suggesting low-dose coaching may be more economical. [68] In practice, ECHO sessions offered considerable overlap with coaching strategies but did not significantly increase MOUD use compared to coaching across medication types during the intervention phase. [68] [69]
This comparative effectiveness research provides pragmatic measures for implementation science in criminal justice settings. The findings suggest that organizational coaching focused on process improvement more effectively addresses the complex barriers to MOUD implementation in jails than knowledge-building approaches alone. [68] The NIATx model's focus on goal-setting and change management proved particularly effective for navigating justice system constraints, where challenges often involve balancing security with treatment and addressing service delivery issues. [68]
The minimal difference between high- and low-dose coaching intensities offers important economic insights for implementation science. The finding that low-dose coaching may be more economical without significantly compromising effectiveness provides practical guidance for resource allocation decisions in implementation efforts. [68] Furthermore, the sustainability phase outcomes, which showed a 7.30% increase in combined MOUD use following the active intervention period, contribute to understanding the maintenance of implemented practices. [68]
The protocol employed a 2×2 factorial design with random assignment to one of four study arms: [68] [70]
The trial was conducted with a national sample of 48 sites, including county jails and community-based treatment providers (CBTPs) that collaborated with the jails. [68] [70] Jails were recruited through national networks including the Justice Community Opioid Innovation Network (JCOIN) and the Bureau of Justice Assistance (BJA), with consideration for diversity based on population size, geographic location, and gender. [68] The intervention period lasted 12 months, with an additional 12-month sustainability phase to assess maintenance of effects. [68] [70]
Diagram 1: Experimental Design Workflow
Objective: To provide organizational coaching using the NIATx process improvement model as a change management framework to overcome implementation barriers. [68]
Personnel: Six trained NIATx coaches with expertise in MOUD implementation and organizational change, all possessing at least 15 years of experience providing NIATx coaching. [68]
Dosage Structure:
Procedural Details:
Mechanism of Action: The coaching strategy focuses on developing internal expertise and providing social support to facilitate organizational change, with particular effectiveness noted in justice settings where it addresses the balance between security concerns and treatment provision. [68]
Objective: To build clinician capacity to adopt and perform MOUD practices through telementoring and case consultation. [68]
Model Structure: The adapted ECHO model began with intensive didactic training in MOUD treatment, followed by a series of monthly tele-video sessions (rather than the traditional weekly sessions). [68]
Session Components:
Mechanism of Action: ECHO aims to enhance MOUD providers' knowledge and self-efficacy to increase confidence in using MOUD, operating primarily through knowledge transfer and expert consultation rather than organizational change. [68]
Table 2: Core Outcome Measures and Assessment Methods
| Domain | Specific Measures | Data Collection Method | Timing |
|---|---|---|---|
| MOUD Utilization | New patient counts for buprenorphine, methadone, injectable naltrexone, combined MOUD | Administrative data extraction | Monthly for 24 months |
| Clinical Outcomes | Initiation and engagement rates for eligible justice-involved persons | Electronic health record review | Monthly for 24 months |
| Provider Outcomes | Percentage of clinicians using MOUD; Organizational readiness and climate | Staff surveys; Organizational assessments | Baseline, 12 months, 24 months |
| Justice Outcomes | Recidivism rates | Criminal justice administrative data | 12 months post-release |
| Implementation Outcomes | Sustainability and fidelity of interventions | Fidelity checks; Implementation logs | Ongoing throughout study |
The primary outcomes included the percentage of eligible justice-involved persons who were initiated onto any MOUD (buprenorphine, extended-release injectable naltrexone, or methadone) and engaged with MOUD use. [70] Secondary outcomes included clinician utilization rates, recidivism, organizational readiness, and sustainability measures. [70]
Table 3: Essential Research Materials and Methodological Components
| Tool/Component | Function/Description | Application in Current Study |
|---|---|---|
| NIATx Coaching Manual | Structured guide for coaching sessions focusing on process improvement and change management | Provided framework for monthly or quarterly coaching calls; ensured intervention fidelity [68] |
| ECHO Curriculum Modules | Didactic materials covering MOUD pharmacotherapy, justice settings, implementation strategies | Formed core educational content for ECHO sessions; standardized knowledge transfer [68] |
| MOUD Fidelity Scale | Assessment tool measuring adherence to evidence-based MOUD practices | Evaluated implementation quality across sites; measured intervention fidelity [68] |
| Organizational Readiness Tool | Validated instrument assessing organizational climate and readiness for change | Measured baseline capacity and monitored change over time [70] |
| Implementation Cost Log | Structured template for documenting resource utilization and costs | Enabled economic analysis comparing high vs. low-dose coaching [68] |
Diagram 2: Implementation Strategy Logic Model
In implementation science, the meticulous study of adaptations—defined as thoughtful and deliberate alterations to the design or delivery of an intervention to improve its fit or effectiveness in a given context—has emerged as a critical frontier for enhancing real-world impact [51] [71]. A significant methodological gap persists in pragmatically linking these systematic modifications to outcomes across the implementation cascade. The central challenge lies in moving beyond mere documentation of what was changed, toward rigorously analyzing how specific adaptations influence proximal implementation outcomes (e.g., feasibility, acceptability) and subsequent distal outcomes (e.g., sustainment, health equity) [51] [72]. This protocol provides a structured, actionable framework for researchers aiming to develop pragmatic measures that precisely connect adaptation characteristics to their multi-level effects, thereby advancing the methodological rigor of implementation science.
The foundation of any adaptation impact analysis is the precise operationalization of the adaptation construct itself. Study teams must delineate what constitutes an adaptation within their specific research context, moving beyond broad definitions to specific, measurable characteristics [51] [72]. We conceptualize adaptations as any planned or unplanned change to the intervention or implementation strategy that occurs before, during, or after implementation [51]. An adaptation study may be a primary, stand-alone investigation or an add-on component to a larger implementation trial [51].
When operationalizing adaptations for measurement, seven key aspects provide a pragmatic foundation for data collection, especially when resources are limited or adaptations are numerous [51] [72]:
Several frameworks provide structured approaches for classifying adaptations and hypothesizing their effects. The Framework for Reporting Adaptations and Modifications-Enhanced (FRAME) and FRAME-Implementation Strategies (FRAME-IS) are comprehensive systems for systematically characterizing what is modified, the nature of the modification, and the goal of the change [51] [71]. The Model for Adaptation Design and Impact (MADI) builds upon these frameworks to guide researchers in creating explanatory models for how adaptations impact outcomes through various mechanisms [51] [72]. Furthermore, the Practical, Robust Implementation and Sustainability Model (PRISM) integrates multilevel contextual domains with RE-AIM outcomes to tailor iterative adaptations based on implementation priorities and progress [51].
Table 1: Foundational Frameworks for Adaptation Analysis
| Framework | Primary Function | Key Constructs Measured | Use Case |
|---|---|---|---|
| FRAME/FRAME-IS | Adaptation Classification & Documentation | What was modified, nature, reason, timing, who decided [51] | Systematic tracking and reporting of adaptations |
| MADI | Impact Modeling & Hypothesis Generation | Intended/unintended effects, mediators, moderators, outcomes [51] | Explaining causal pathways from adaptation to outcome |
| PRISM/RE-AIM | Outcome-Driven Adaptation | Reach, Effectiveness, Adoption, Implementation, Maintenance [51] | Guiding iterative adaptations based on implementation progress |
| 3x3 Matrix Model | Simple Categorization | Focus (intervention/strategy/context) x Timing (pre/active/sustainment) [71] | Initial, high-level mapping of adaptation types |
Objective: To systematically document, classify, and prioritize adaptations throughout the implementation lifecycle.
Materials & Procedures:
Analysis: Conduct descriptive analysis of adaptation characteristics (type, frequency, timing). Use content analysis for qualitative data on rationales. Create a summary table of prioritized adaptations for impact analysis.
Objective: To analyze relationships between specific adaptations and subsequent implementation and effectiveness outcomes.
Materials & Procedures:
Analysis: Employ analytic techniques ranging from comparative analysis (e.g., pre/post adaptation) to multivariate modeling, considering timing, bundling, and contextual moderators [51]. Qualitative comparative analysis (QCA) can be useful for examining complex causal pathways.
Table 2: Adaptation Outcome Specification Template
| Adaptation Description | Intended/ Unintended | Equity-Relevant? (Y/N) | Proximal Outcome(s) (e.g., Acceptability, Feasibility) | Distal Outcome(s) (e.g., Sustainment, Health Equity) | Hypothesized Mechanism |
|---|---|---|---|---|---|
| Example: Simplified patient materials for low-literacy populations | Intended | Y | Provider Perceived Feasibility Patient Understanding | Increased Reach Reduced Disparities in Engagement | Enhanced comprehensibility reduces barrier to engagement |
| Example: Shift from group to individual sessions due to space constraints | Unplanned | N | Increased Facilitator Time/Cost *Maintained Fidelity to Core Components | Potential Reduction in Program Capacity Possible Enhanced Participant Outcomes | Individualized attention may improve effectiveness but reduce efficiency |
Objective: To use real-time implementation data to proactively guide and inform necessary adaptations.
Materials & Procedures:
Analysis: Focus on trend analysis of implementation outcomes over time, correlating the timing of specific adaptations with changes in outcome trajectories.
The following diagram illustrates the core conceptual workflow for analyzing the impact of adaptations, from systematic documentation through to outcome evaluation, highlighting key decision points.
Conceptual Workflow for Analyzing Adaptation Impact
Table 3: Key Methodological Reagents for Adaptation Research
| Tool/Reagent | Function | Application Notes |
|---|---|---|
| Structured Adaptation Log | Standardized documentation of adaptations in real-time. | Integrate into existing meeting structures. Use FRAME constructs as column headers. [51] |
| FRAME/FRAME-IS Coding Guide | Systematic classification of adaptation characteristics. | Train coders for reliability. Adapt modules to research questions. [51] [71] |
| Outcome Specification Template | Links specific adaptations to hypothesized proximal/distal outcomes. | Complete for each prioritized adaptation before impact analysis. [51] [72] |
| Stakeholder Interview Guide | Elicits undiscovered adaptations and contextual rationale. | Include perspectives from multiple stakeholder levels (leadership, staff, recipients). [51] |
| RE-AIM or PRISM Metrics | Tracks key implementation outcomes to guide iterative adaptations. | Select 2-3 high-priority outcomes for rapid-cycle feedback. [51] [71] |
| Qualitative Comparative Analysis (QCA) | Analyzes complex, contingent causal pathways for outcomes. | Suitable for studies with multiple cases/sites and bundled adaptations. [51] |
This protocol provides a comprehensive methodological pathway for rigorously connecting specific adaptations to their multi-level outcomes. By systematically defining the adaptation construct, prospectively tracking modifications using established frameworks, explicitly specifying hypothesized outcome pathways, and selecting analytic methods suited to the complexity of implementation contexts, researchers can significantly advance the pragmatic measurement of adaptation impacts. The resulting evidence is critical for distinguishing between adaptations that enhance fit and effectiveness versus those that potentially undermine an intervention's core active ingredients, ultimately enabling more effective, equitable, and sustainable implementation in real-world settings.
Within implementation science, the systematic evaluation of strategy dosage—defined as the intensity, frequency, and duration of an implementation strategy—is critical for understanding its mechanism and effect on outcomes [73]. Coaching is a widely used but heterogeneously applied implementation strategy; clarifying the dosage of different coaching models is essential for developing pragmatic measures that are useful, compatible, and easy to use in real-world settings [74]. This protocol provides a structured approach for comparing high- and low-intensity coaching models, detailing applicable pragmatic measures and methodologies for assessing their impact on implementation outcomes.
Coaching dosage encompasses more than just contact hours. This framework breaks it down into three interdependent dimensions:
The distinction between high- and low-intensity coaching often lies in their theoretical foundations and operationalization:
Table 1: Core Characteristics of High- and Low-Intensity Coaching Models
| Characteristic | High-Intensity Coaching | Low-Intensity Coaching |
|---|---|---|
| Theoretical Basis | Facilitation/Process-Oriented [75] | Goal-/Outcome-Oriented [75] |
| Primary Style | Facilitator, adapting to team maturity [76] | Formal Authority, Expert [76] |
| Relationship | Personal, collaborative partnership [73] | Structured, standardized support [76] |
| Customization | High, tailored to context and needs [73] | Low to moderate, more standardized |
| Key Function | Boundary spanning, enabling implementation [73] | Fidelity support, technical assistance [76] |
Evaluating coaching strategies requires measures that are psychometrically sound and pragmatic—defined as useful, compatible, acceptable, and easy for stakeholders [74]. The Psychometric and Pragmatic Evidence Rating Scale (PAPERS) was developed through stakeholder-driven processes to assess these qualities in implementation measures [74]. When selecting measures, consider their pragmatic rating alongside psychometric properties to ensure feasibility in real-world settings.
To standardize the reporting of coaching dosage, track the following metrics:
Table 2: Quantifiable Metrics for Coaching Strategy Dosage
| Dosage Dimension | Specific Metrics | Data Collection Method |
|---|---|---|
| Intensity | - Coach-to-staff ratio- Coach expertise level- Session customization level | Administrative records; Session ratings |
| Frequency | - Number of sessions per week/month- Consistency of schedule | Coaching logs; Meeting calendars |
| Duration | - Length of single session (minutes)- Total program lifespan (months) | Session timestamps; Project records |
| Cumulative Dose | - Total contact hours per participant | Calculated from logs (Frequency x Duration) |
Coaching impacts outcomes across multiple levels. The following framework, adapted from training and implementation science, categorizes these outcomes and suggests potential measures [75].
Table 3: Outcome Measures for Evaluating Coaching Effectiveness
| Outcome Level | Definition | Example Measures | Relevant Coaching Intensity |
|---|---|---|---|
| Affective Outcomes | Changes in attitudes, motivation, self-efficacy [75] | - Implementation Climate Scale- Self-Efficacy Questionnaires | High-intensity coaching may have stronger effects due to tailored support [73]. |
| Cognitive Outcomes | Acquisition of knowledge and problem-solving strategies [75] | - Knowledge tests- Conceptual mapping exercises | Both models can be effective, depending on content delivery. |
| Skill-Based Outcomes | Acquisition, mastery, and automaticity of new skills [75] | - Fidelity scores- Direct observation checklists | High-intensity with in-vivo observation may be superior [73]. |
| Behavioral Outcomes | Observable changes in workplace behavior [75] | - Audit and feedback reports- Supervisor ratings | Both models can drive change; high-intensity may accelerate it. |
| Organizational Results | System-level changes and sustainment [75] | - EBI Sustainment rates- Program penetration | High-intensity models may better address systemic barriers [73]. ``` |
Aim: To quantitatively and qualitatively compare the processes and outcomes of high- and low-intensity coaching models supporting the same Evidence-Based Intervention (EBI).
Methodology:
Aim: To evaluate the pragmatic qualities of implementation outcome measures when used in the context of a coaching strategy.
Methodology:
The following diagram visualizes the logical workflow and key decision points for planning an evaluation of coaching strategy dosage, integrating the EPIS framework phases.
This table details essential "research reagents"—the core tools and materials required to conduct rigorous studies on coaching dosage.
Table 4: Essential Reagents for Coaching Dosage Research
| Item/Category | Function in Research | Exemplars & Notes |
|---|---|---|
| Coaching Session Coding Framework | To qualitatively classify and quantify coaching styles and interactions over time. | Adapted Grasha-Riechmann Framework (e.g., Facilitator, Formal Authority, Expert styles) [76]. |
| Pragmatic Measure Rating Tool | To evaluate the usability and feasibility of implementation measures in real-world coaching contexts. | Psychometric and Pragmatic Evidence Rating Scale (PAPERS) [74]. |
| Dosage & Fidelity Tracking System | To systematically record the intensity, frequency, and duration of coaching delivered and received. | Standardized logging templates (electronic or paper) for coaches; key metrics outlined in Table 2. |
| Implementation Outcome Measure Battery | To assess the multi-level effects of coaching dosage. | Validated scales measuring acceptability, appropriateness, feasibility, fidelity, and sustainment [5]. |
| Stakeholder Engagement Panel | To ensure the research design and measures are relevant and pragmatic from multiple perspectives. | A group comprising coaches, implementation staff, and service users to guide the research [1]. |
The next diagram illustrates the pivotal role of the coach in bridging the inner context (organization) and outer context (broader system), a key mechanism through which dosage influences implementation success [73].
Hybrid effectiveness-implementation trials represent a transformative approach in clinical and public health research, designed to accelerate the translation of evidence-based interventions into routine practice. Traditional randomized controlled trials (RCTs), while considered the gold standard for establishing causal inferences, often suffer from significant limitations including prolonged timelines and substantial research-to-practice gaps [77]. The conventional staged approach, which focuses first on establishing efficacy under ideal conditions before considering real-world implementation, creates an unacceptable time lag between evidence generation and widespread clinical adoption [78]. Hybrid trials address this critical bottleneck by simultaneously investigating both clinical effectiveness and implementation strategies within a single study framework.
The conceptual foundation for hybrid trials was formally established to bridge the divide between highly controlled clinical research and the complex environments where care is actually delivered [78]. These trials recognize that healthcare systems are complex adaptive systems, and understanding the influence of situational context is equally as important as establishing clinical efficacy, even while the evidence base is being developed [77]. By integrating these complementary aims, hybrid designs multiply the amount of learning that can come from a trial without proportionately increasing costs, answering broader questions than those related to effectiveness alone [77].
Hybrid trials exist on a continuum and are categorized into three distinct types based on their primary focus and the relative emphasis on effectiveness versus implementation outcomes [77]. Each type serves different research purposes and addresses different stages in the intervention development and implementation pathway.
Type 1 Hybrid Trials primarily focus on intervention effectiveness outcomes while concurrently exploring the context for future implementation [78] [77]. In this design, the clinical effectiveness aim remains paramount, but researchers gather preliminary data on implementation barriers, facilitators, and potential strategies that could inform future dissemination efforts. This approach is particularly valuable when there is already some evidence of efficacy but understanding real-world contextual factors is necessary before broader scale-up.
Type 2 Hybrid Trials maintain a dual focus, with co-primary aims assessing both intervention effectiveness and implementation outcomes [77]. These trials simultaneously investigate whether an intervention works and how best to implement it, testing both the clinical intervention and specific implementation strategies. This design is optimal when there is stronger preliminary evidence for effectiveness, but significant questions remain about optimal implementation approaches.
Type 3 Hybrid Trials primarily focus on implementation outcomes while secondarily exploring clinical effectiveness [77] [79]. These designs are employed when effectiveness is already well-established, and the primary research question concerns how best to integrate the intervention into routine care. The secondary effectiveness aim typically examines how clinical outcomes relate to implementation fidelity, uptake, and integration within real-world settings.
Table 1: Comparison of Hybrid Trial Types and Traditional Designs
| Design Aspect | Effectiveness RCT | Hybrid Type 1 | Hybrid Type 2 | Hybrid Type 3 | Implementation Study |
|---|---|---|---|---|---|
| Primary Aim | Determine effectiveness of an intervention | Determine effectiveness while exploring implementation context | Dual: Determine effectiveness AND assess implementation strategy | Determine impact of implementation strategy while exploring clinical outcomes | Determine impact of implementation strategy |
| Units of Randomization | Individual or Cluster | Individual or Cluster | Individual or Cluster | Cluster (typically) | Cluster (typically) |
| Comparison Conditions | Placebo, treatment as usual, competing intervention | Placebo, treatment as usual, competing intervention | Placebo, treatment as usual, competing intervention | Historical practice or treatment as usual | Historical practice or treatment as usual |
| Population Framework | Single population with strict inclusion/exclusion | Two populations: primary with strict criteria; secondary (implementers) | Two populations: including both recipients and implementers | Two populations: primary system-level; secondary with strict criteria | Single population focusing on system level |
| Measurement & Outcomes | Quantitative clinical effectiveness ± cost | Primary: quantitative effectiveness; Secondary: mixed methods implementation context | Co-primary: clinical effectiveness AND implementation outcomes | Primary: implementation outcomes; Secondary: clinical effectiveness | Implementation outcomes only |
The use of theoretical approaches, including theories, models, and frameworks (TMFs), is a critical element in designing robust hybrid trials. A recent scoping review of hybrid type 1 trials found that 76% cited at least one theoretical approach to guide their implementation components [78]. These TMFs provide critical understanding of the complex systems within which implementation occurs, offer explicit assumptions that can be tested and validated, and help connect findings across studies from various clinical settings [78].
The most commonly applied framework in hybrid trials is the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework, utilized in 43% of hybrid type 1 trials according to the scoping review [78]. This framework helps researchers plan for and evaluate the public health impact of interventions across multiple dimensions. Other frequently used TMFs include process frameworks that outline implementation steps, determinant frameworks that explain influences on implementation outcomes, and evaluation frameworks that specify implementation outcomes of interest [77].
Theoretical approaches in hybrid trials are most often applied to justify implementation study design, guide selection of study materials, and analyze implementation outcomes [78]. When used systematically, these approaches accelerate future translation of evidence-based practices into routine care and optimize patient outcomes by providing insights into how interventions function within specific contexts.
Type 1 hybrid trials require meticulous planning to balance the primary effectiveness focus with systematic exploration of implementation context. The protocol begins with clearly defining dual aims: a primary aim focused on clinical effectiveness and a secondary aim examining implementation context [78] [77]. The sampling framework typically involves two populations: the primary patient population with strict inclusion/exclusion criteria, and secondary populations including clinicians, healthcare providers, or other stakeholders who can provide insights into future implementation.
Measurement strategies in Type 1 designs combine quantitative clinical effectiveness measures with mixed methods approaches (interviews, surveys, audits) to assess feasibility, barriers/enablers to implementation, acceptability of the intervention, and sustainability potential [77]. For example, a Type 1 trial might randomize patients to receive either a new clinical intervention or usual care while concurrently surveying providers about intervention acceptability and observing system-level factors that might influence future implementation.
The implementation context exploration typically focuses on identifying barriers and facilitators to sustainable implementation of the clinical intervention [78]. This includes assessing organizational readiness, resource requirements, workforce capabilities, and potential adaptations needed for different settings. Data collection for implementation components often occurs throughout the trial period but may be concentrated at specific timepoints to capture evolving perspectives as stakeholders gain experience with the intervention.
Type 2 hybrid trials employ a more complex protocol with co-primary aims that receive equal emphasis. The protocol must specify rigorous methods for both effectiveness and implementation questions, often requiring expertise in both clinical trials methodology and implementation science [77]. These trials frequently use cluster randomization designs where units such as clinics, hospitals, or healthcare systems are randomized to different implementation strategies while still collecting patient-level effectiveness data.
The implementation component in Type 2 trials typically tests specific implementation strategies, such as educational outreach, coaching, facilitation, audit and feedback, or clinical decision support systems [77]. The protocol should clearly define these strategies using standardized terminology and specify their theoretical basis, core components, and adaptation potential. Measurement includes both implementation outcomes (acceptability, adoption, fidelity, cost) and clinical effectiveness outcomes, with careful attention to temporal relationships between implementation processes and clinical effects.
An exemplar Type 2 protocol is illustrated in a study testing the "Beliefs and Attitudes for Successful Implementation in Schools for Teachers (BASIS-T)" strategy, which targets volitional and motivational mechanisms of educator behavior change [79]. This protocol employs a blocked randomized cohort design with an active comparison control condition, recruiting 276 teachers from 46 schools to evaluate main effects on both implementation mechanisms and student outcomes.
Type 3 hybrid trials prioritize implementation aims while collecting clinical effectiveness data to understand how implementation quality influences outcomes. These protocols typically employ cluster randomized or stepped-wedge designs where the unit of randomization is the implementation site [77]. The primary focus is on testing implementation strategies, with clinical effectiveness data often collected through subsamples of patients, medical record review, or administrative data to reduce measurement burden [77].
The protocol for a Type 3 trial explicitly defines the evidence-based practice being implemented and specifies the implementation strategies being tested. For example, a hybrid Type 3 trial of the "Building Better Caregivers" online workshop for rural dementia caregivers uses the RE-AIM framework to guide evaluation across multiple dimensions including Reach, Effectiveness, Adoption, Implementation, and Maintenance [80]. This protocol combines a randomized controlled trial for effectiveness assessment with mixed methods to evaluate implementation outcomes under real-world conditions.
Type 3 protocols pay particular attention to contextual factors that influence implementation success and often include rigorous process evaluations to understand how and why implementation strategies work or fail in different settings. These protocols typically plan for iterative adaptations to implementation approaches based on ongoing data collection, balancing fidelity to core implementation strategy elements with necessary contextual adaptations.
Hybrid trials generate complex quantitative data spanning both clinical effectiveness and implementation outcomes. Systematic organization of these data is essential for clear interpretation and reporting. The following table summarizes key outcome domains and representative measures for hybrid trials:
Table 2: Outcome Measures for Hybrid Trials
| Domain | Specific Outcomes | Representative Measures | Data Collection Methods |
|---|---|---|---|
| Implementation Outcomes | Acceptability, Adoption, Fidelity, Penetration/Reach, Sustainability | Acceptability of Intervention Measure (AIM), Fidelity checklists, Adoption rates, Penetration rates | Surveys, administrative data, direct observation, interviews |
| Clinical Effectiveness Outcomes | Patient-level health outcomes, Behavior change, Symptom improvement | Clinical symptom scales, Functional status measures, Behavioral assessments, Biomarkers | Patient surveys, clinical assessments, medical record review, laboratory tests |
| Implementation Mechanisms | Attitudes, Subjective norms, Self-efficacy, Intentions to implement | Theory of Planned Behavior constructs, Implementation Climate Scale | Provider surveys, focus groups, structured observations |
| Contextual Factors | Organizational readiness, Leadership engagement, Resource availability | Organizational Readiness for Change, Implementation Climate Scale | Key informant interviews, organizational surveys, document review |
Analysis approaches for hybrid trials must account for the multi-level nature of the data, with clinical outcomes often nested within implementation contexts. Mixed effects models can appropriately handle clustering of patient outcomes within providers or sites, while mediation analyses can test hypothesized mechanisms linking implementation strategies to clinical outcomes [79]. Type 2 and 3 hybrid trials frequently employ mixed methods approaches, integrating quantitative and qualitative data to develop a comprehensive understanding of both whether interventions work and how they function in specific contexts.
The conceptual and operational workflows for hybrid trials can be effectively communicated through standardized diagrams that clarify the relationships between trial components, implementation strategies, and outcomes. The following DOT language scripts generate visual representations of these complex relationships:
Diagram Title: Hybrid Trial Continuum
Diagram Title: Hybrid Trial Protocol Workflow
Conducting rigorous hybrid trials requires specialized methodological resources and tools. The following table outlines essential "research reagents" for designing, implementing, and analyzing hybrid trials:
Table 3: Essential Research Reagents for Hybrid Trials
| Research Reagent | Function/Purpose | Exemplars |
|---|---|---|
| Implementation Frameworks | Guide design, measurement, and interpretation of implementation components | RE-AIM, CFIR, Theoretical Domains Framework, Consolidated Framework for Implementation Research [78] [80] |
| Implementation Strategy Specifications | Define and operationalize specific implementation strategies | Strategy specification templates from Expert Recommendations for Implementing Change (ERIC), Implementation Research Logic Model [77] [79] |
| Implementation Outcome Measures | Assess implementation success across multiple dimensions | Acceptability of Intervention Measure (AIM), Fidelity checklists, Adoption rates, Sustainability measures [77] |
| Mixed Methods Integration Tools | Facilitate integration of quantitative and qualitative data | Joint displays, triangulation protocols, convergence coding matrix [78] [80] |
| Theory of Change Models | Articulate hypothesized causal pathways from strategies to outcomes | Logic models, process models, mechanism maps [79] |
| Context Assessment Tools | Evaluate organizational and system-level factors influencing implementation | Organizational Readiness for Change, Implementation Climate Scale, Inner/Outer Context assessments [79] |
These research reagents provide the methodological infrastructure necessary to conduct rigorous hybrid trials. Their systematic application helps ensure that hybrid trials generate meaningful insights about both intervention effects and implementation processes, advancing the dual goals of establishing what works and how to make it work in real-world settings.
Hybrid effectiveness-implementation trials represent a paradigm shift in clinical research methodology, offering a powerful approach to accelerating the translation of evidence into practice. By simultaneously examining clinical effectiveness and implementation processes, these designs address critical bottlenecks in the traditional research pipeline that have delayed the delivery of evidence-based care to patients [77]. The three hybrid types provide flexible options for researchers based on the existing evidence for clinical interventions and the prominence of implementation questions.
As the field advances, methodological sophistication in hybrid trials continues to increase, with stronger theoretical grounding, more precise specification of implementation strategies, and more integrated mixed methods approaches [78]. Future directions include developing standardized reporting guidelines for hybrid trials, refining methods for adaptive hybrid designs that can respond to emerging findings, and creating funding mechanisms that support the complex interdisciplinary teams required for this work [77]. As one expert provocatively stated, "In the future, all 'good' trials will be hybrid, in some way" [77], reflecting the growing recognition that understanding implementation context is not secondary to establishing efficacy, but fundamental to realizing the public health impact of clinical interventions.
The development of truly pragmatic measures in implementation science demands a fundamental shift from top-down, exclusively expert-driven models to inclusive, stakeholder-engaged processes. As synthesized from the latest research, success hinges on integrating diverse perspectives from the outset, employing rigorous yet flexible methodological frameworks like case studies and MOST, and continuously validating measures through comparative effectiveness research. The future of biomedical and clinical research depends on this evolution. By embracing these approaches, researchers and drug development professionals can create implementation strategies and measures that are scientifically sound, contextually adept, and powerful enough to systematically close the agonizing 17-year gap between discovery and practice, ultimately ensuring that evidence-based interventions achieve their full public health potential.